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ABSTRACT. 
Over the past decade long distance marathon running has become an important 
recreational activity. There is evidence that males with high levels of physical activity 
have some impairment of fertility. In order to investigate this further, 24 male marathon 
runners were studied over a period of a year. Each runner was assessed at regular 
intervals using hormonal profiles, anthropomorphic indices and semen evaluation. The 
training time and distance run increased progressively over the first five months of the 
study as the runners prepared for the Two Oceans marathon. 
Analysis of the serum hormonal profiles in this longitudinal study showed that the 
prolactin level increased when comparing the initial study month with the rest of the 
year and the progesterone level decreased. However the luteinizing hormone (LH), 
follicle stimulating hormone (FSH), testosterone and estradiol (E2) levels remained 
unchanged. When the runners were divided into a high and low training group 
according to the distance run in the preceding week, the only significant difference was 
the lower mean serum FSH level in the high training group. 
A decrease in semen volume was demonstrated as the training time increased. This 
trend was reversed as the runners' training decreased after the Two Oceans marathon. 
The percentage of morphologically normal spermatozoa showed an initial significant 
decrease in the first month of training. However, no significant difference was observed 
throughout the rest of year. An overall downward trend in semen motility in the first 5 
months of the study was shown but this was only significant if the first and fifth study 
months were compared. The decrease in semen motility coincided with the period of 
maximum training. Since patients with an adequate sperm count but decreased motility 
have impaired fertility this finding is of considerable importance. In addition to the 
decrease in motility, there was a decrease in the percentage of morphologically normal 
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spermatozoa when the initial month of low physical activity (December) was compared 
to all of the subsequent months analysed. This, too, is an important finding as the 
percentage of morphologically normal spermatozoa correlates directly with fertilisation 
and pregnancy rates. When the results were analysed in the high and low training 
months there was a significant difference in mean semen count and semen morphology. 
The mean count was higher in the high training group and this group also had a 
significantly higher normal morphology. However, there was no significant difference 
in semen volume and motility in the high and low training groups. 
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INTRODUCTION. 
During the last decade, public interest in weight control and general health has led to 
running becoming an important recreational and health activity. This widespread 
interest in long distance running has led to observations of altered endocrine physiology 
in such groups, particularly in women runners. It has been shown that disturbances 
occur in normal hypothalan1ic-pituitary-gonadal (H-P-G) function in individuals 
participating in endurance training and competitive running (Ayers et al., 1985). 
Evidence suggests that acute exercise and endurance training has a suppressive effect on 
the H-P-G axis in men and women (McColl et al., 1989). Although there has been 
considerable investigation into the effects of exertion on reproductive function in 
women, there is very little information describing the chronic effects of endurance 
training on H-P-G function in men (Wheeler et al. , 1984). 
Endurance training in women has been associated with reproductive dysfunction. A 
prospective study demonstrated that the abrupt imposition of strenuous aerobic exercise 
combined with caloric restriction can suppress luteal function, ovulation and 
menstruation in women potentially leading to reproductive dysfunction (Bullen et al., 
1985). A cause-effect relationship between exercise and infertility is, however, difficult 
to demonstrate because of the presence of life-style variables which also may influence 
the reproductive system (Loucks et al., 1989). Clinical medicine tends to look at 
fertility, potency or menstruation as an "all-or-none" phenomenon, as normal or 
abnormal yet subtle and reversible alterations occur outside the "disease" state (Prior 
1987). An exercise-induced dL:ficicncy of 60nado .. opin releasing hormone (GnRH) 
results in amenorrhoea. The prevalence of "athletic amenorrhoea" is variable and has 
been reported as 1 - 43% compared to 2 - 5% in the general population (Rogol et al., 
1992). Reduced pulse frequency of GnRH may be the cause of the persistent 
anovulation observed in females participating in endurance training (Reame et al., 
1985). Although the exact mechanisms causing such alterations in reproductive 
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function are not known, sustained aerobic exercise effectively stimulates the 
endogenous opiate system (Colt et al., 1981). Studies in humans indicate that 
endogenous opioids and exogenous morphinomimetic compounds inhibit, whereas 
opiate-receptor antagonists acutely stimulate LH and possibly FSH secretion (Cicero et 
al., 1980). Inhibition in the secretion of GnRH in women is manifested by amenorrhoea 
- a well defined end-point. This has led to the extensive investigation of women long-
distance marathon runners. Acute strenuous exertion also elicits a demonstrable 
increase in serum prolactin concentrations in women runners (Shangold et al., 1981 ). 
Although hyperprolactinaemia can be associated with clinical or biochemical 
hypogonadism, the role of exercise induced prolactin secretion in reproductive 
disturbances attributed to strenuous exercise is not defined. Endurance training in 
women has also been reported to decrease estradiol levels and reduce gonadotropin 
response to GnRH (Boyden et al., 1983, Prior et al., 1981). These changes may result 
in a shortened luteal phase, oligomenorrhoea or amenorrhoea (Wall et al., 1983). The 
diminished luteal function and amenorrhoea appear to be separate end-points in 
different types of women (Loucks et al., 1989). In contrast the clinical signs of 
hypogonadism in males are more subtle and often clinically inapparent. The findings 
among various studies suggest that the threshold for exercise or training induced H-P-G 
suppression is much higher in men than in women (McColl et al, 1989). 
In both sexes there are numerous other variables which may affect fertility, including 
body weight, acute weight loss, emotional distress, physical illness and sleep disruption 
(Prior, 1987). Some of these variables may also be influenced by exercise per se. Given 
these multiple factors, studies attempting to isolate exercise as the causative agent must 
co, trol for these vari ables. Prospective, longitudin '.' l studies with each ~u bject acting as 
her I his own control best achieve this. However, there are no published prospective 
studies where exercise is the major variable, and where gonadal and pituitary hormones 
have been sampled. Whilst many features of the H-P-G axis are common to both males 
and females, additional complex control mechanisms are involved in woman in order to 
regulate cyclical reproductive phenomena relating to germ cell production, and the 
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maintenance of an appropriate micro-environment for fertilisation and development of 
the zygote, should one be formed (Ur, 1992). Disruption of reproductive function in 
women athletes may not be directly associated with factors in the athletic life-style 
itself, but, rather with the degree to which the H-P-G axis is disturbed in the individual 
woman (Loucks et al., 1989). 
Research regarding the effects of exercise training on male reproductive function has 
primarily focused on the serum hormone modifications with little emphasis on 
determining the effects on spermatogenesis (Acre et al., 1993). A few studies have 
documented semen parameter changes in runners but the findings have been 
inconsistent and often contradictory (Bagatell and Bremner, 1990; Ayers et al., 1985; 
Griffith et al., 1990). The effects of exercise on spermatogenesis have not, therefore, 
been clearly established. 
Hypothalamic-pituitary-gonadal (H-P-G) axis 
The hypothalamus regulates the secretion of pituitary hormones through neurohormonal 
mechanisms involving hypothalamic-releasing and inhibiting factors. Hypothalamic 
influence on reproduction is most likely reflected in the pulsatile characteristics of LH, 
secreted simultaneously with gonadotropin-releasing hormone (GnRH) (Prior, 1987). 
H-P-G function is subject to physiological regulation by metabolic substrates, hormones 
and other factors. In females the menstrual cycle depends on the pulsatile release of 
gonadotropins, which, in turn, are controlled by the frequency and amplitude of GnRH 
from the hypothalamus. Gonadal hormones, severe caloric deficit and stress, both 
physiological and psychological, are common factors in the disruption of menstrual 
cycles and alterations in the physiological release of LH and FSH (Rogol et al., 1992). 
The endocrine control of testicular function involves a complex, finely regulated 
interaction between the central nervous system, in particular the hypothalamus, the 
anterior pituitary gland and the testes. The testis consists of two structurally and 
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functionally distinct compartment, each of which is responsible for one of the two 
major physiological functions of the testes. The seminiferous tubules produce and 
transport spermatozoa, which determines a man's ability to conceive children (ie 
fertility). The interstitial or Leydig cells produce and secrete sex steroid hormones, 
primarily testosterone, that mediates the development and maintenance of primary and 
secondary sexual characteristics and normal sexual behaviour and potency, as well as 
playing an important role in the initiation and maintenance of spermatogenesis 
(Matsumoto and Bremner, 1987). To understand the effects of physical activity on the 
H-P-G axis, a knowledge of the factors regulating GnRH, gonadotropin release and 
those involved in controlling the gonads is essential. 
Gonadotropin releasing hormones (GnRH). 
GnRH is a decapeptide which stimulates the release of both pituitary gonadotropins. 
The relative amounts of follicle stimulating hormone (FSH) and luteinizing hormone 
(LH) vary. With low dosages of GnRH however, more LH than FSH is released. Only a 
single GnRH has, to date been identified and synthesised (Schally et al., 1973). 
Pulsatile GnRH is necessary for normal function at the pituitary level and is as 
important in men as in women (Naftolin et al., 1972). Hypothalamic GnRH neurons are 
regulated by numerous stimulatory and inhibitory neurotransmitters (eg catecholamine, 
serotonin and amino acids) and neuropeptides (eg opioids) systems. Many of the 
neuromodulatory systems participate in the regulation of GnRH-secreting neurons by 
higher neural centres (eg the limbic system and cerebral cortex) and by gonadal 
steroids. Therefore, the hypothalamic-GnRH neuronal system serves an important 
integrating function in the regulation of gonadal function. It receives input from higher 
central nervous system centres and from negative feed-back from the gonads to alter 
GnRH output. Alterations in Gn_RH secretion regulate pituitary gonadotropin secretion 
which, in turn, control gonadal function (Matsumoto and Bremner, 1987). Highly 
trained male athletes have been reported to have deficient GnRH secretion (MacConnie 
et al., 1986). Barron et al reported major hypothalamic, pituitary and exogenously 
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stimulated hormone dysfunction in long distance male runners who were "over-trained" 
(Barron et al., 1985). GnRH is also found within the central nervous system, ovary and 
testis. The function of GnRH at these sites remains to be defined (Bevan and Scanlon, 
1992). It does not, however, appear to have a direct effect on testicular steroidogenesis 
in humans (Rajfer et al., 1987). 
Pituitary gonadotropins. 
The substances that directly affect gonadal function, including spermatogenesis, are the 
anterior pituitary gonadotropins, FSH and LH. Both are glycoproteins, and both are 
composed of two subunits, termed alpha and beta, linked by non-covalent bonds. The 
alpha subunit of the two hormones are similar, if not identical, (Shome and Parlow, 
1974) and are also common to two other glycoproteins; thyroid-stimulating hormone 
(TSH) and the placental gonadotropin, human chorionic gonadotropin (hCG). The beta 
subunits, on the other hand, give each hormone its biological and structural specificity 
(Hafez, 1976). 
In males LH binds to specific, high-affinity membrane receptors on Leydig cells of the 
testis and stimulates testicular steroidogenesis via a cyclical adenosine mono-phosphate 
(AMP) mediated process. LH stimulation leads to increased secretion of testosterone, 
the major steroid product of the testis (Matsumoto and Bremner, 1987). Similarly, in 
females LH bind to specific receptors in the ovary and together with FSH regulates 
ovarian function. LH acts on the theca interna cells, regulating their androgen 
production and LH is also responsible for the destruction of the follicular wall which 
precedes ovulation. 
On the other hand, FSH in males binds to specific receptors on the plasma membrane of 
Sertoli cells and probable spermatogonia of the seminiferous tubule compartment of the 
testis. FSH receptor binding results in stimulation of adenylate cyclase activity, increase 
in intracellular cyclical AMP and protein kinase, and production of a variety of proteins 
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that may be important in regulating spermatogenesis. FSH is necessary for the initiation 
of spermatogenesis (Braunstein, 1983). In contrast FSH in females acts primarily on 
granulosa cells, promoting ovarian follicular maturation. 
LH and, to a lesser extent, FSH are secreted into the peripheral circulation by the 
anterior pituitary gland in a pulsatile fashion (Bardin, 1978). The published evidence 
concerning the effect of exercise on pulsatile LH release is conflicting. In male runners 
the basal pulsatile LH release was reported to be similar to normal in runners with a 
training distance of approximately 80 km per week (Rogol et al, 1984), and decreased 
in runners with a much higher (120 - 200 km) weekly training distance. Both of these 
groups had normal testosterone levels. (MacConnie et al, 1986). In the latter study there 
was no significant effect of acute exercise on pulsatile LH release although the runners 
, 
had lower LH pulse frequency and amplitude compared to sedentary men (MacConnie 
et al., 1986). In a more recent study in females there was no effect on the pulsatile 
characteristics of LH during the early follicular phase of the menstrual cycle by exercise 
(Weitman et al. , 1990). However, in an earlier study in female runners LH 
concentrations were depressed during exercise followed by a significantly increased 
LH pulse amplitude and pulse increment during two hours of recovery, with no 
corresponding change in FSH. Mean LH and FSH levels were reported to be 
significantly higher during the two hours of recovery than during the exercise (Keizer et 
al, 1984). These observations have direct implications for designing prospective 
exercise programmes in which measurements of exercise effect on gonadotropin release 
are determined. 
In men the pulse pa tten of LP :rnd FSH is vari :i hlc bet"'een and within sub_jPcts and in 
women the LH pulse pattern depends on the stage of the menstrual cycle. In the 
follicular phase there is a marked progressive increase in LH pulse frequency which is 
associated with an increased estrogen secretion from the developing ovarian follicles. 
Positive estrogenic feed-back ultimately induces the pre-ovulatory LH surge at which 
time there is a considerable increase in the frequency and size of LH pulses. In contrast, 
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LH cycle frequency is relatively low during the luteal phase of the menstrual cycle 
(Bevan and Scanlon, 1992). 
Circulating FSH levels are regulated by non-steroidal factors with inhibin being the 
most clearly identified substance. Inhibin is synthesised predominantly in ovarian 
granulosa cells in the female and Sertoli cells in the male. Inhibin levels increase during 
the late follicular phase and the hormone acts synergistically with estradiol to inhibit 
FSH synthesis and release, although this inhibition is over-ridden at the time of the pre-
ovulatory gonadotropin surge (Bevan and Scanlon, 1992). It is not known whether 
inhibin also exerts a negative feedback control at a hypothalamic locus, but 
testosterone, and estradiol are also capable of inhibiting the secretion of FSH (Sherins 
et al., 1982). The role of inhibin in the male is poorly defined and the significance of 
inhibin in relation to disorders of gonadal function , such as infertility, is currently 
unknown (Ur, 1992). 
Full maturation of spermatozoa appears to require not only FSH but also testosterone 
(Braunstein, 1983). The control of LH in men operates primarily by negative feedback 
because normal levels of gonadal steroids inhibit secretion. Other mechanisms that have 
been implicated in altered gonadotropin secretion in women include loss of estrogenic 
positive feed-back or, conversely, enhanced sensitivity to estrogenic negative feed-back 
(Rogol et al. , 1992). Both testosterone and estradiol can inhibit LH secretion and 
testosterone can be converted to estradiol in the brain and pituitary (Santen, 1975). The 
mechanism of testosterone-mediated gonadotropin inhibition at the pituitary level is not 
known but possibly a reduction of gonadotropin receptor number or uncoupling of 
receptor~ fro m subse('.uent biochemical events is the cause (Cum ming et al. , 1989). 
Endogenous opiates have a role in the negative feedback actions of androgen and 
estrogen on pulsatile LH secretion in men (Veldhuis et al. , 1984). 
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Gonadal steroid hormones. 
The three steroids of primary importance in male reproductive function are testosterone, 
dihydrotestosterone and estradiol (Braunstein, 1983). The gonadal steroid hormones are 
secreted by the interstitial cells and in addition to their role in the development of the 
secondary sexual characteristics, testosterone in particular, is of fundamental 
importance in the initiation and maintenance of spermatogenesis (Steinberger et al., 
1973). Normal levels of testosterone are necessary for sexual differentiation of male 
internal and external genitalia during embryogenesis, development and maintenance of 
secondary sexual characteristics at the time of puberty, maintenance of sexual 
functioning and behaviour, and negative feed-back regulation of gonadotropin secretion 
in adults (Matsumoto and Bremner, 1987). 
The mechanism by which testosterone affects spermatogenesis and the actual quantity 
of testosterone necessary in the seminiferous tubules to maintain normal sperm 
production and fertility are not well defined. Over 95% of the testosterone is secreted 
by the testicular Leydig cells with the remainder derived from the adrenals (Lee, 1978). 
Testosterone is a potent androgen which in circulation is mainly bound to SHBG (44%) 
and albumin (54%). Only the unbound steroid (approximately 2%), and probably the 
albumin-bound fraction, is biologically active. Estrogens raise SHBG levels whereas 
androgens tend to lower them (Duignan, 1992). 
Androgen deficiency in adult males is characterised by reduced libido and potency, 
infertility, behavioural changes, weakness and fatigue and loss of androgen-dependent 
hair. During prolonged physical stress combined with lack of food, metabolism is 
directed at energy mobilisation from fat and proteins. All catabolic hormones, such as 
glucocorticoids, increase, whereas anabolic hormones, such as testicular androgens, 
decrease (Opstad, 1992). Several authors have reported that serum testosterone levels 
decrease after acute prolonged exercise such as marathon running, but return to normal 
within 24 hours (Marville et al., 1979; Dessypris et al., 1976; Aakvaag et al., 1978). 
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There is now evidence that endurance training may have chronic effects on pituitary 
gonadal function in male distance runners in a manner similar to that described in 
women. It has been shown that the mean levels of total as well as non-sex hormone-
binding globulin-bound and free testosterone levels were significantly lower than 
controls, although levels remained within the physiological range (Wheeler et al., 
1984). These authors suggested that the lower testosterone levels in runners must reflect 
differences in either clearance or production of the hormone because the non-
specifically bound portions were reduced with no significant difference in serum 
binding. In a more recent article, Wheeler again stated that the lower testosterone levels 
in exercising men suggest that peripheral mechanisms are responsible and that this 
decreased testosterone was not related to changes in pulsatile LH release (Wheeler et 
al., 1991). Opstad, in contrast, also noted a decrease in testosterone during prolonged 
physical stress, but concluded that this decrease in testicular androgens is mainly 
regulated through the H-P-G axis (Opstad, 1992). 
Dihydrotestosterone and estradiol are derived not only by direct secretion from the 
testes but also by conversion in peripheral tissues of androgen and estrogen precursors 
secreted by both the testes and adrenals. Approximately 80% of the circulating 
concentrations of these two steroids is derived from such peripheral conversion 
(MacDonald et al. , 1979). It has been shown in a study that there is a decrease in all 
androgen hormones, testicular as well as adrenal, after hours and days of continuos 
physical exercise (Opstad, 1992). Although testosterone is the major product, 17-
hydroxyprogesterone, progesterone and pregnenolone are also secreted by the testes 
(Han1mond P f al., 1977) Some pregn<" nolnne may be converted to progesterone which 
is then hydroxylated before being converted to 17-hydroxyprogesterone and then to 
androstendione and ultimately testosterone. This pathway is, however, not commonly 
followed in humans (Lee, 1978). Progesterone is also secreted by the adrenal cortex. 
Little is known concerning the precise mechanism of release of progesterone in men or 
of its transport in the blood, although it is probably mostly bound to plasma proteins. It 
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has a short half-life of approximately 5 minutes in the blood, and is converted to 
pregnanediol mainly in the liver, and subsequently conjugated with glucuronic acid and 
excreted in the urine chiefly in the form of glucuronide. The effect of progesterone 
includes a rise in basal metabolic rate and body temperature, and stimulation of 
respiration. The biological functions of plasma progesterone and 17-
hydroxyprogesterone in the male are not known (Griffin et al., 1992). Estrogen 
formation in the testis is regulated by gonadotropins and circulating androgens can be 
aromatised to estrogens in the extraglandular tissues (Sitteri et al., 1973). 
Prolactin 
Prolactin is necessary for normal manufacture of sex steroids within the testis but 
hyperprolactinaemia may result in the decreased testosterone production and impaired 
libido as seen in athletes (Wheeler et al., 1984). Raised prolactin levels due to either 
psychotropic medications or a pituitary prolactinoma can present with gonadal 
dysfunction due to suppression of GnRH secretion by prolactin (Wang and Swerdloff, 
1992). Prolactin plays an important role in control of the reproductive axis in men and 
women. In men, decreased steroidogenesis can occur with hypoprolactinaemia via 
decreased Leydig cell sensitivity to LH, or hyperprolactinaemia probably via a central 
mechanism (Rubin et. al., 1978). Prolactin potentiates the effect of LH on Leydig cells 
(Davies et al., 1980). 
Stress. 
The possibility that stress could lead to reproductive dysfunction has been considered 
for many years . Both ohysical and psychological stress has been linked to abnormal 
H-P-G axis function and can therefore affect spermatogenesis (Acre et al., 1993; Ayers 
et al., 1985). In man there are a number of modulating factors, both individual and 
related to social circumstances, that have potent effects on the way that social stress is 
reflected in endocrine activity (Herbert, 1987). In addition life-events may negatively 
influence reproductive function by increasing the inhibitory neuro-endocrine 
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modulation of opioids on the H-P-G axis (Genazzani et al., 1991). 
Most studies on stress in human subjects have been of rather short duration, up to a few 
hours, and frequently associated with the administration of drugs, anaesthesia or 
surgery. The numerous discrepancies reported in the literature on the response to stress 
may be related not only to differences in the type of stress, but also to interference by 
additional factors such as drugs, anaesthesia and possibly the duration of the stress 
(Aakvaag et al., 1978). 
The pituitary-prolactin release represents one area of controversy regarding the stress 
response. Various studies have yielded conflicting results. Herbert et al showed that 
prolonged social stress imposed by a forth-coming examination resulted in prolactin 
levels in male medical students showing a small, but significant increase (Herbert, 
1987). In contrast, the serum level of prolactin was significantly suppressed during a 
severe physical combat course in army personnel (Aakvaag et al. , 1978). In the latter 
study it is, of course, not possible to separate the effects of physical from those of 
emotional stress on the prolactin levels. The underlying mechanism for this reduction in 
prolactin is not known, but it might be postulated that dopamine could be involved. 
Dopamine is elevated during stress resulting in a reduction in prolactin levels which 
may in turn influence testosterone levels (Borowski et al., 1976). 
In men, an acute decrease in serum testosterone levels in association with a variety of 
stressful conditions such as surgery or myocardial infarction has been observed 
(Cartensen et al., 1972; Wang et al., 1978). The rate of testosterone decline seems to be 
related to the severity of the surgical stress (Aono et al. , 1976). A si milar decline in 
testosterone levels without a concomitant decrease in LH was also observed in patients 
after vigorous exercise (Cumming et al., 1983). In men, over 95% of circulating 
testosterone is derived from the Leydig cells of the testis and the adrenal-testicular axis 
may have biological implications on the reproductive adaptation to stress (Lipsett et al., 
1966). 
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In females it is well recognised that both physical and psychological stress can result in 
amenorrhoea, but the mechanism by which stress alters GnRH secretion remains 
unknown (Biller et al., 1990). Other factors, such as the opioid and dopaminergic 
systems, have been implicated as potential mediators of stress-related amenorrhoea in 
women (Quigley et al., 1980). These have not been well researched in men. 
Nutrition and Energy Balance 
Epidemiological observations have pointed to a relationship between nutrition, fat 
stores and the H-P-G axis. Most exercise studies in men and women show some 
decrease in relative fat weight (Boyden et al., 1983; Bullen et al., 1985). It is unlikely 
that a given individual has a absolute weight or percent fat which will alter 
reproduction. However, change in weight or fat weight is important. Runners who loose 
weight during training had more significant menstrual cycle alterations than those 
whose weight remained constant, despite having comparable exercise levels (Bullen et 
al., 1985). There are no studies published which have correlated weight change with 
changes in semen parameters, a less well-defined end-point. 
Athletic activity requires significant increase in caloric intake usually as carbohydrates 
(Bullen et al, 1985). Nutrition has a major influence on neuro-reproductive function as 
exercise requires fuel and the careful regulation of energy stores. Weight loss and re-
feeding are associated with menstrual cycle and hormonal changes in women (Prior, 
1987). Weight or fat loss seems to interact in an additive way with exercise to alter 
reproduction. 
Nutrition most likely affects reproduction by modifying the pulsatile release of GnRH 
at the hypothalamic level (Prior, 1987). When exercise is added to weight loss or 
negative energy balance there is an increased likelihood, other factors being equal, of 
reproductive suppression. Clinical data suggests that these changes are reversible with 
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either a decrease in training and no weight gain, or with weight gain and no change in 
training (Prior, 1987). 
Spermatogenesis and Semen Evaluation 
The testis is primarily under the control of the hypothalamic-pituitary axis. The 
hormonal milieu necessary for the initiation and maintenance of spermatogenesis in 
man is poorly understood. It is well established that sperm production requires the 
stimulatory actions of pituitary gonadotropins and the role of androgens in the initiation 
of the spermatogenic process and its progression through the meiotic prophase was 
demonstrated by Steinberger (Steinberger et al., 1970). In a study to evaluate the effect 
of exercise on sperm production, Ayers showed that, despite significantly depressed 
gonadal steroid levels, chronic endurance training (40-80 miles/week) was not 
associated with a detrimental effect on sperm production in most men. Morphologic 
evaluation revealed no significant abnormalities of spermatogenesis, stress pattern, or 
abnormal forms (Ayers et al., 1985). However, the exact effects of strenuous exercise 
on male fertility remains to be precisely defined. 
In man sperm production is a biological constant which takes approximately 70 days for 
the process to progress from spermatogonia to spermatid (Heller and Clermont, 1964). 
The gonadal steroid hormones are known to be involved in both the initiation and 
maintenance of spermatogenesis. The rate of spermatogenesis cannot be altered by 
hormonal suppression or stimulation, other noxious agents such as radiation, or a 
change in temperature. Once a spermatogonium becomes committed to the process of 
spermatogenesis, it appears that a period of about 70 days in man is mandatory to 
complete spermatogenesis (Hafez, 1976). 
Spermatogenesis in the adult begins with the spermatogonia and proceeds through a 
number of simple mitotic divisions that culminate in the formation of a primary 
spermatocyte. The primary spermatocyte then passes through six substages as a result of 
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meiosis: preleptotene, leptotene, zygotene, pachytene, diplotene and diakinesis. After 
these six sub-stages are completed, secondary spermatocytes are formed. The secondary 
spermatocytes undergo a mitotic division resulting in the formation of two spermatids 
from each spermatocyte. Finally, spermiogenesis results in the formation of mature 
spermatozoon from the spermatids (McConnell et al., 1984). 
Spermatogenesis is under the control of the central nervous system with the various 
afferent impulses integrated in the hypophysiotropic area of the hypothalamus (Halasz 
et al., 1962). This area contains nerve cells and fibres rich in biogenic amines, notably 
norepinephrine and dopamine. These neurotransmitters lead to the stimulation of other 
specialised cell collections containing peptidergic neurons. The releasing hormones are 
then secreted from the nerve terminals in close proximity to the capillary loops that 
form the primary plexus of the hypophyseal portal system. The specialised 
monoaminergic and peptidergic neurons are grouped together to form "centres", and 
each of the anterior pituitary hormones is under the control of one such centre. The 
precise anatomical localisation of the gonadotropin-controlling centres in the human 
hypothalamus is unknown, but are likely to be situated in the arcuate nucleus and 
medial basal hypothalamus (Hafez, 1976). The effect of major athletic competition on 
hormonal levels, libido and sperm production remains largely unexplored. The general 
perception has been that strenuous exercise is not associated with a significant decrease 
in fertility, but this is probably a reflection of a lack of available data rather than 
scientific facts. Baker has suggested that a decrease in fertility may occur in males who 
participate in strenuous physical activity (Baker et al. , 1984.). In addition anecdotal 
data have also suggested that libido may be impaired in some runners during periods of 
intense endurance training (Wheeler et al. . 1984). The aetiology of this is not clear. 
Reduced testosterone levels may play a role but chronic fatigue could also be a 
significant factor (Wheeler et aL, 1984.). More recently a study has shown significant 
changes in semen characteristics associated with endurance training in the form of 
running, suggesting that running quantitatively and qualitatively modifies the semen 
parameters (Arce et al., 1993). 
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Several hormonal factors appear to influence spermatogenesis in laboratory animals and 
man. Spermatogenesis is under the control of FSH and LH, whose secretion is regulated 
by gonadal steroids and inhibin (Knuth et al. , 1989.). In adult males LH and FSH 
regulate both Leydig cell and seminiferous tubule function . The sex steroids 
manufactured by the Leydig cells interact with neuronal elements in the hypothalamus 
and gonadotropin-secreting cells in the pituitary to affect particularly LH levels. FSH 
appears to be regulated by non-steroidal factors from the seminiferous tubules with the 
most clearly identified substance from this source being inhibin which serves to reduce 
FSH levels (Wall et al., 1985). The significance of inhibin in relation to disorders of 
gonadal function, such as infertility is currently unknown. The FSH receptor-hormone 
formation at the Sertoli cell results in the initiation of the spermatogenesis process (Catt 
and Pierce, 1978). However, in a series of studies by Matsumoto et al, they 
demonstrated that normal serum levels of FSH are not required for qualitatively normal 
spermatogenesis in man since sperm counts in the range of 20 x 106 to 50 x 106 were 
typically found in a variety of hormonal milieus, which included severely suppressed 
FSH levels. To achieve quantitatively normal levels of sperm production, FSH 
replacement was required (Matsumoto et al. , 1986). This implies that the physiological 
role of FSH in man is the quantitative stimulation of spermatogenesis. 
The process of spermatogenesis has an absolute requirement for androgens. 
Testosterone in circulation is bound to a specific, high affinity, low capacity protein, 
sex hormone binding globulin (SHBG), and with low affinity to albumin, which has a 
large capacity. In the Sertoli cells, testosterone plays an essential role in the facilitation 
nf the spermatogenesis process. The pulsatil e release of LH results in some fluctuations 
of testosterone levels in the circulation. There is also a circadian cycle imposed where 
large nocturnal elevations in · testosterone are observed (Bardin, 1978). Plasma 
testosterone has been shown to be constant between 8 and 10 am (Kalra and Kalra, 
1977). Testosterone is essential for primary spermatocyte to complete meiosis and there 
is general agreement that testosterone is the physiological feedback inhibitor of LH in 
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man (Sutton et al. , 1973). 
Several other non-hormonal influences have a direct effect on semen parameters. 
Chronic high dose alcohol ingestion is directly toxic to the testis and may affect the 
testis and pituitary indirectly through liver disease (Boyden and Pamenter, 1983). 
Heavy cigarette smoking is associated with reduction in sperm quality (Handelsman et 
al., 1984). Opiates are inhibitory to the H-P-G axis and lead to hypogonadism and 
infertility. 
The period of continence preceding collection of the semen specimen has a remarkable 
influence on spermatozoan concentration but has little effect on motility or morphology 
(Freund, 1963). Most laboratories do set a period of continence for the patient, but this 
varies from laboratory to laboratory. A fixed period of continence preceding the 
collection of a specimen means that the specimen is no longer a random sampling of the 
patient's spermatozoan output at his usual frequency of ejaculation. This means that the 
data are no longer appropriately subject to statistical tests based on random sampling 
and also that the complex relationship between spermatozoan output in the ejaculate 
and spermatozoan production by the testes, is further confounded by setting a fixed 
period of continence. It has been shown that individuals respond quite differently to 
experimental variations in the frequency of intercourse and duration of continence; 
some men show very large changes in spermatozoan output, and some quite modest 
changes (Freund, 1963 ). 
Transitory elevation of testicular temperature have been shown to depress 
spermatogenesis. Tn a study hy La7.arus and Zorgni otti thP critica l roint at which 
testicular thermoregulation was disrupted occurred when the oral body temperature 
reached 37.70C (Lazarus and Zorgniotti, 1975). In another study by Macleod an 
elevation of body temperature in man in conjunction with a simultaneous elevation of 
the environmental temperature resulted in a decrease in the sperm count and changes in 
the morphology and motility of the sperm. The effect of hyperpyrexia upon 
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spermatogenesis did not become apparent for nearly 3 weeks and may have lasted for a 
period of 50 days thereafter (Macleod and Hotchkiss, 1941). In contrast to this 
McConnell concluded that temperature changes associated with endurance exercise did 
not affect sperm production rates in humans. However, the results of McConnell and 
co-workers must be interpreted with caution as the duration of exposure to high 
temperatures during exercise may not have been long enough to alter spermatogenesis. 
In this study peak rectal temperature was not obtained until the last 10 minutes of the 45 
minute exercise period (McConnell and Sinning, 1984 ). It should be noted that the 
scrotum possesses a very efficient capacity of thermoregulation, and that the 
temperature in the testis is markedly lower than the body temperature. In an article by 
Politoff a seasonal rhythmicity of spermatogenesis was noted and they postulated this 
might be due to external, seasonally induced temperature fluctuations, which could also 
be partially responsible for fluctuations in testicular temperature. Peak spermatogenesis 
was noted in autumn and winter but peak levels of testosterone and LH were also noted 
at these times. Prolactin, on the other hand peaked in spring (Politoff et al., 1989). A 
study of out door workers during a hot summer showed a reduction in sperm counts and 
motility when compared with winter months (Levine et al., 1990). Such environmental 
factors are being identified in increasing numbers by careful epidemiological studies 
with objective measurement of semen parameters. 
The role and importance of semen analysis has grown over the past two decades as 
gynaecologists who treat infertile couples have recognised that evaluation of semen is a 
logical early step in the overall infertility work-up. Predominantly male factor 
abnormalities account for at least one third of the infertile couples and male infertility is 
the most common clinical presentation of testicular dysfunction (Wang and Swerdloff, 
1992). The traditional semen parameters monitored in most laboratories including 
semen count, motility and morphological features cannot clearly distinguish between 
infertile and fertile men. Despite this, multivariate discriminant analyses using 
conventional semen parameters showed that sperm concentration and morphology are 
variables providing the most consistent and valuable information discriminating fertile 
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and infertile men (Wang and Swerdloff, 1992). Sperm morphology was found to have 
the least variability within a patient (Sherins et al. , 1977), and was the most useful in 
predicting the success of in vitro fertilisation (Kruger et al., 1988). The sperm count 
plays a crucial role in the definition of infertility. However, other criteria such as 
motility and rate of forward progression are also integral parts of the semen analysis. 
Semen analysis at Groote Schuur Hospital is based primarily on rating of the number, 
motility and morphology of the spermatozoa in the specimen. Biochemical analysis of 
semen in human infertility have attempted to relate the concentration of single 
compounds to accessory organ function (eg. fructose levels to seminal vesicle function 
and zinc levels to prostrate function) (Freund, 1963). Seminal plasma, which makes up 
more than 95% by volume of ejaculated semen, is an extracellular fluid that is a 
composite mixture of secretions originating from the accessory organs of reproduction. 
The secretions of the various glands are specific in chemical composition, and it has 
been proposed that this specificity be used as an indicator of the functional status of the 
accessory glands. The measurement of single substances like fructose or zinc in semen 
has not yielded a reliable clinical indicator of the cause of infertility (Hafez, 1976). In 
this study no biochemical analysis were performed on the semen samples. 
Several additional characteristics of semen are also noted and recorded in different 
laboratories. These include semen liquefaction, viscosity, colour, spermatozoan 
agglutination and the presence of extraneous cells. While there have been attempts to 
link abnormalities in these characteristics with infertility, the cause-and-effect 
relationship between any of the characteristics and infertility has yet to · be proved 
(Hafez, 1976). These parameters were not, therefore, included in our study. However, 
g naecoln~ists treating the infertile male denend to a large extent on the findings of 
semen analysis in determining the course and the efficacy of treatment. 
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AIMS OF THE STUDY 
This study was undertaken to determine the serum hormonal and semen changes during 
intense training for marathons. A group of male runners was studied over a year, 
between December 1989 and November 1990, at 1-3 monthly intervals. Weight, 
hormone and semen parameters were measured at each visit. 
The aims of the study were: 
1. To determine the range and means for specific serum hormones and 
semen parameters longitudinally in a group of runners training for a 
marathon. 
2. To assess whether significant changes occur in weight, BMI, hormone 
and semen parameters during training for a marathon. 
3. To evaluate if changes occur in serum hormone levels and semen 
parameters during months of low training compared with months of high 
training. 
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SUBJECTS AND METHODS 
Study population 
Twenty four male long-distance runners volunteered to participate m the study. 
Informed consent was obtained from each subject. The study was approved by the 
Ethics and Research Committee of the University of Cape Town Medical School. 
The mean age of the runners was 38.2 years (range 25-54 years). All participants 
intended to run the Two Oceans Marathon (56 km) five months after the start of the 
study and ten the Comrades Marathon (90 km) six weeks later. During the 12 months of 
the study, the athletes' training consisted of individualised programs which became 
progressively more intense in preparation for the Two Oceans marathon and then tailed 
off gradually towards the end of the year. Each runner was responsible for estimating 
and recording the distance trained in the preceding week. 
Study Time and Parameters 
The study was started in December 1989 and was completed in November 1990. A 
baseline assessment of the runners was done in December 1989 which included weight 
and height. They were then reassessed in January, February, April, May, August and 
November of 1990. 
At each visit the runner was questioned on his general health. In addition the following 
was recorded: 
1. The distance run weekly since the previous visit. 
2. The runner's weight. 
The following samples were obtained: 
1. Ten millilitres of clotted blood 
2. A semen sample. 
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Calculation of the body mass index (BMI). 
The BMI of all of the runners was calculated for each visit as follows: BMI = weight 
(kg)/height (m2). 
Blood sample collection. 
Non-fasting blood samples were obtained from the subjects between 7.00 am and 9.00 
am. The blood san1ples were allowed to clot at room temperature and the serum was 
separated by centrifugation and stored at -2ooc until assayed. All the samples from 
each participant were analysed in the same assay thereby avoiding inter-assay variation. 
Determination of FSH, LH, progesterone, testosterone, prolactin and E2 
levels. 
LH and FSH was measured by immunoradiometric assay (IRMA) using the Serono 
"Maiaclone" kits. Total testosterone (T.Testo) and progesterone (Prog) were measured 
with the antibody coated tube radioimmunoassay (RIA) kits from the Diagnostic 
Products Corporation (DPC). Prolactin (PRL) was measured with the double antibody 
RJA kit from Pharmacia Diagnostics and E2 with the IRMA coated tube assay from 
Medgenix. 
The limit of detection of the standard curve and the biological sensitivity of the assay 
for the serum samples are given in Table 1. 
The measurem ':i ts of the samples in this study were performed in durlicate in a si ngle 
assay for each hormone and the coefficient of variation (CV) of the duplicates in the 
assays was 3.5% for FSH; 4.1 % for LH; 3% for T. Testo; 5.1 % for Prog; 3% for PRL 
and 3.6% for E2. The intra-assay coefficient of variation (% CV) for each assay at low, 
medium and high levels are given in Table 1. 
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< 15 ng/ml 
< 2 nMol/L 
1.5 - 9.2 miu/ml 
1 - 14 miu/ml 
9.2 - 37 nmol/ml 
100 - 500 pMol/L 
Table 1 
Details of assays 
INTRA-ASSAY C.V. SENSITIVITY 
Assay Type Kit Low Medium High Study STD Samples 
Curve 
LH IRMA Serono at <5 at<lO at>IO 4.1% 0.2 0.7 
(mIU/ml) Maiaclone 3.7% 2.7% 2.8% 
FSH IRMA Serono at <5 at<lO at>IO 3.6% 1.4 1.8 
(mIU/ml) Maiaclone 5.7% 4.8% 3.9% 
Prog RIA Diagnostic at<5 at <10 at>lO 5.1% 0.2 1.2 
(nmol/1) Prod Corp 7.8% 6.1% 8.3% 
Prolactin RIA Pharmacia at 9.0 at 22 at43 3.0% 1.5 5.0 
(ng/ml) Diagnotics 4.4% 2.3% 2.8% 
E2 IRMA Medgenix at450 at 1000 at >1000 3.6% 20 43 
(pmol/1) 4.5% 5.9% 6.8% 
Testos RIA Diagnostic at 10.6 at27 3.0% 0.7 1.7 
(nmol/1) Prod Corp 4.5% 8.5% 
This illustrates the laboratory details and quality assurance of the techniques used to 
assay the hormonal profiles in the runners. 
Semen Sample collection 
Semen analysis was performed on a fresh masturbation sample for physical 
characteristics including volume, count, motility , morphology and antibodies. A 
specimen bottle was supplied to each patient to be used at the next collection which 
avoided the problem of receiving specimens in a variety of used and possibly 
c::rntan::nated containe rs. The use of thc~A plas ti c c0ntainers ha 1,cc n preced d hy 
careful chemical and biological studies of their effects on spermatozoan motility and 
survival. No fixed period of continence was specified. Masturbation was the routine 
method of collection of a specimen. This was either performed at the laboratory or at 
home and brought directly to the laboratory for analysis. Coitus interruptus was 
discouraged as this results in the loss of the first (sperm-rich) fraction of the ejaculate, 
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and the use of a rubber condom may result in a specimen that does not yield a useful 




Volume was measured to the nearest tenth of a millilitre in a 10 millilitre graduated 
test-tube. 
Motility and rate of forward progression. 
The raw semen was mixed by placing the semen specimen into a shaker for several 
minutes. A drop of well-mixed semen was placed on a clean glass slide, covered with a 
cover-slip and left for a few minutes. Five to ten microscope fields for each slide were 
examined under a magnification of both xlO and x40 objectives for percentage of 
motile sperm and speed of forward progression. Percent motility was rated from 100% 
(all spermatozoa motile) to 0% (no spermatozoa motile) and is estimated to the nearest 
5% (Mcleod, 1973). 
The rate of forward progression was estimated using the arbitrary criteria of Hotchkiss. 
This estimates the speed of progression and is scored on a scale of O to 4 (with a plus or 
minus sign after the number). Four was designated as the best quality of progression 
whilst no significant progression observed in a sample was scored as 0. The level 2+ 




Depending on the estimated sperm concentration, a dilution 1/10, 1/20 or 1/100 of the 
well-mixed spenn was made accordingly and counted using an improved Neubauer 
hemocytometer. 
Spermatozoan Morphology. 
Percent normal morphology was rated from the examination of 200 spermatozoa in 
stained smears. A thin, well spread smear was made in a manner similar to that used in 
making blood smears. The smears were air-dried and stained according to the method 
described by Papanicolaou. (Papanicolaou, 1942). There is considerable variation 
among laboratories in the rating of spermatozoan morphology. There is little agreement 
on what the words "normal" and "abnormal" mean when they are applied to 
spermatozoan morphology. The greatest single difficulty in the rating of spermatozoan 
morphology lies in the disagreement among investigators as to what constitutes a 
"normal" or "standard" spermatozoan. This disagreement comes from the fact that 
"normal" human spermatozoa vary considerably from the ideal composite drawings in 
textbooks and are not uniform in shape or size. Many different concepts of the 
appearance of a normal human spermatozoon are evident from the literature, and the 
usual description includes a sketch of the "ideal type" of normal spermatozoon which 
usually resembles a tennis racket. This model is often accompanied by several drawings 
of "typical" abnormal cells, which are labelled with the investigator's own set of 
descriptive terms. In this study, morphology was assessed according to the Tygerberg 
system (Kruger et al., 1986) which uses strict criteria where "borderline" forms are 
considered abnormaL Two hundred spermatozoa were asse~o:)ed and classifo.,J into 
groups. In this laboratory, a spermatozoa is considered normal when the head has a 
smooth, oval configuration with a well-defined acrosome comprising about 40% to 
70% of the spenn head. Also, there must be no neck, midpiece, or tail defects and no 
cytoplasmic droplets of more than one-half the size of the sperm head. 
32 
Mixed antibody reaction (MAR) 
The IgG MAR test was performed on all samples by mixing semen with sensitised red-
blood cells. To this mixture IgG antiserum is added. The formation of mixed 
agglutinates between particles and motile spermatozoa indicates the presence of IgG 
antibodies on the spermatozoa. The reaction is regarded as positive when more than 
10% of motile spermatozoa are adherent to the particles. 
Standard International normal values for semen parameters 
Volume 2.0-6.0 ml. 
Motility > 40% 
Count > 20 million/ml 
Morphology > 40% 
Mar test 0-< 10% (negative). 
Figures and Tables 
The figures were produced using Harvard graphics 3.0 and the tables using Microsoft 
word for Windows. 
Statistical Methods 
Statistical analysis were performed on an Apple Machintosh SE computer using the 
statistics packages Multistat version 1.01 (distributed by Biosoft, 22 Hills road, 
Cambridge ) and Systat version 3.2 (distributed by Systat Inc., 2902 Central street, 
Evanston. 1160201 ;U.S.A.). A normal distribution of values was assumed, and analyses 
were performed using paired/unpaired Student "t" tests and Spearman correlation 




The individual data for each of the runners are illustrated in tables 17 - 40. This 
includes information on the weight, height, body mass index, age, hormonal profile, 
semen analysis and the distances run per week for each study month during the study 
period. Each of the runners is represented by his initials for reasons of confidentiality. 
The key to the tables is given in appendix 1. 
Clinical Characteristics 
The clinical characteristics of the study group are listed in Table 2. Thirteen of the 
runners had previously fathered children and one subject had been investigated for 
infertility and subsequently found to have poor semen parameters. (Subject A.B -Table . 
21). The ages of the study group ranged from 25 years to 54 years with a mean of 38.2 
years. Their heights varied from 163 centimetres to 190 centimetres with a mean height 
of 176 centimetres. 
Table 2 
IIll c aractenstics o t e stu ty group er ·caJ h f h d 
Minimum Maximum Mean (SD) 
Age (years) 25 54 38.2 (8.7) 
Height (cm) 163 190 176 (6.0) 
Weight (kg) 54.8 92.9 74.6 (10) 
BMI(kgtm2) 20.2 30.7 23.7 (2.6) 
Low Training 0 55 28.7 (18.5) 
Distance / week (km) 
High Training 60 160 84.9 (20.8) 
Distance/ week (km) ---
The runners' characteristics including age, height, weight and body mass index. The 
mean values are illustrated with the standard deviation (SD) indicated in brackets 
together with the high.and low training time distances run. 
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Training Time 
There was a significant increase in training distance between December and January 
(T=4.347 p<0.001), December and February (T=5.321 p<0.001) and December and 
April (T=3.874 p=0.001) and also between January and February (T=2.944 p=0.006) 
(Table 3). In table 3 the T statistic and p values are included for the comparison of 
training times between the months indicated. Significant differences are shown with the 
asterix (*). This increase in training distance was in preparation for the marathon which 
was run in April. (Figure 1). There was no significant difference in training distance 
when comparing December with April to November. A significant decrease in training 
was noted after the marathon in April. 
Figure 1 
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This illustrates the distance run by the study group for each of the study months (mean 
+/- SEM). Distance run in km/week is shown on the y axis and months are illustrated on 
the x axis. 
C ompanson o e s f th di ta 
January February 
December T= 4.347 T= 5.321 
(baseline) p=<0.001 * p =<0.001* 
January T= 2.944 











p =<0.001 * 
T = 1.643 
o = 0.116 
T= 0.309 
p = 0.761 
gea 0 es u 1y mon ch f th t d th s 
May August November 
T= 1.343 T = 0.031 T= 0.830 
p = 0.195 p = 0.976 p=0.417 
T= 0.909 T= 3.112 T= 3.997 
o = 0.375 0 =0.006* o=0.001* 
T = 1.701 T= 4.838 T = 8.381 
p =0.106 0=<0.001* D =<0.001 * 
T= 2.601 T= 4.156 T= 5.015 
o = 0.019* o=0.001* D =<0.001 * 
T= 1.174 T = 1.357 
p = 0.256 p = 0.194 
T= 0.559 
p = 0.583 
The month of December (used as a baseline) is compared with each of the other months 
studied. The individual months are also compared with each other. The T statistic and p 
value for each comparison is illustrated. (* = significant) 
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Anthropomorphic indices 
Over the year long study there was a significant change in the runners' weight (Table 4) 
and body mass index (Table 5). In table 4 the T statistic and p values are included for 
the comparison of weight between the months indicated. Significant differences are 
shown with the asterix (*). The same is shown for BMT in table 5. Tnitially there was a 
significant decrease in weight between December and January (T=4.347 p<0.001), 
December and February (T=5.321 p<0.001) and December and April (T=3.874 
p=0.001) although the change in the BMI over the same period was not significant 
(Figure 2 and 3). Thereafter there was a significant increase in both the weight and BMI 






Weight during training 
D J F M A M J J A S O N 
MONTH 
This illustrates the weight in kilograms of the study group for each of the study months 





















Body m~ index during the study period 
kg/m,. 
D J F M A M J J A S O N 
MONTH 
This illustrates the body mass index in kg/ m2 of the study group for each of the study 
months (mean+/- SEM). Body mass index is shown on they axis and months are 
illustrated on the x aAis. 
Table 4 
C ompansono f th e runners . htd we1g. unng th t d es u lY pen 
January February April May August November 
December T = 4.437 T = 5.321 T= 3.874 T = 0.586 T= 3.048 T=3.811 
(baseline) p=<0.001 * p=< 0.001 * p = 0.001 * p = 0.565 p = 0.007* p = 0.001 * 
January T = 1.026 T = 0.034 T= 0.023 T= 3.868 T= 4.378 
P=0.317 p = 0.973 p = 0.982 p=0.001* P=< 0.001 * 
February T = 1.063 T = 0.958 T= 4.908 T= 4.805 
p=0.301 P = 0.351 p=<0.001 * D=< 0.001 * 
April T = 0.393 T= 4771 T = 6.026 
I 
~ 
IJ = 0 .Lu:J l)=<v.vll i p=< 0.001 
May T= 4.304 T= 3.923 
P=0.001* D=0.001* 
August T = 1.551 
D = 0.138 
The month of December (used as a baseline) is compared to each of the other months 
studied. The individual months are also compared with each other. The T statistic and p 
value for each comparison is illustrated (* = significant) 
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Table 5 
C ompansono f h t e runners Ly massm ex unng t 'bod . d d . h estu 1y pen d ·oo 
January February April May August November 
December T= 0.923 T = 2.007 T= 0.768 T= 0.739 T= 3.080 T= 3.799 
(baseline) D = 0.365 D = 0 .058 D = 0 .451 D = 0.469 D = 0.006* D = 0.001 
* 
January T = 1.415 T= 0.037 T= 0.308 T = 3.917 T = 4.448 
D=0.172 D = 0.971 D = 0 .762 D=0.001 * D = 0.001* 
February T= 1.666 T = 1.109 T = 5.351 T = 5.294 
o=0.112 p = 0 .282 0=<0.001 * D=< 0.001 * 
April T = 0.048 T= 4.554 T = 6.022 
0 = 0 .962 o=<0.001 * D=< 0.001 * 
May T= 4.965 T = 4.392 
0=<0.001 * O=< 0 .001* 
August T = 1.238 
p = 0 .232 
The month of December (used as a baseline) is compared to each of the other months 
studied. The individual months are also compared with each other. The T statistic and p 




There was a significant increase in prolactin levels when comparing December with all 
the other months studied (Table 6). In table 6 the T statistic and p values are included 
for the comparison of mean prolactin levels between the months indicated. Significant 
differences are shown with the asterix (*). Prolactin levels increased from December to 
January but then there was no further significant change over the rest of the study 
period (Figures 4 and 5). Prolactin minimum and maximum levels remained well within 
the normal range for males with the mean value of each study month consistently in the 
lower quarter of the normal range. 
Figure 4 






























































DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV 
MONTH 
This illustrates the maximum and minimum prolactin levels (in ng/ml) of the runners for 
each of the months studied. The median value is indicated with the mark .. The normal 
range for prolactin in males is < 15 ng/ml. Prolactin levels are shown on the y axis and 
the months are illustrated on the x axis. 
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Figure 5 
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This illustrates the mean prolactin level of the study group for each of the study months 
(mean + I - SEM). Prolactin levels in ng / ml are shown on the y axis and months are 









ompanson o pro actin eves o e runners f 
Table 6 
I . 1 I f th d urmg 
January February April Mav 
T= 3.448 T= 3.493 T= 5.150 T=5.017 
p = 0.002 * p = 0.002 * P=<0.001* p=<0.001* 
T= 0.584 T = 1.770 T = 1.966 
o = 0.566 o = 0.091 o = 0.063 
T = 1.127 T = 1.853 
o = 0.274 o = 0.080 
T= 0.674 
11 = 0.509 
es u 1y pen th t d "od . 
Aul!USt November 
T= 3.859 T = 4.418 
p = 0.001* p=<0.001* 
T = 1.205 T= 0.922 
o = 0.243 o = 0.368 
T= 0.776 T= 0.256 
o = 0.447 o = 0.801 
T= 0.250 T= 0.400 
p = O.R06 r = 0.694 
T= 0.238 T = 0.144 
o = 0.815 o = 0.888 
T= 0.712 
p = 0.486 
The month of December (used as a baseline) is compared with each of the other months 
studied. The individual months are also compared with each other. The T statistic and p 
value for each comparison is shown. (* = significant) 
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Progesterone 
When compared with the baseline concentration (December) progesterone levels fell 
significantly in May, August and November (Table 7). In table 7 the T statistic and p 
values are included for the comparison of mean progesterone levels between the months 
indicated. Significant differences are shown with the asterix (*). Progesterone minimum 
and maximum levels for each study month remained well within the normal range for 
males with the mean value of each study month consistently in the lower half of the 
normal range (Figures 6 and 7). 
Figure 6 






















































DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV 
MONTH 
This illustrates the maximum and minimum progesterone levels (in nmol/1) of the 
runners for each of the months studied. The median value is indicated with the mark -. 
The normal range for prolactin in males is < 2 nmol/1. Progesterone levels are shown on 
the y axis and the months are illustrated on the x axis. 
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Figure 7 










DJ FMAMJ JASON 
MONTH 
I 
This illustrates the mean progesterone level of the study group for each of the study 
months (mean + I - SEM). Progesterone levels in nmol/1 are shown on the y axis and 
months are illustrated on the x axis. 
C f ompanson o progesterone 
January February 
December T= 0.235 T = 1.275 
(baseline) p = 0.816 p = 0.216 
January T= 0.928 





eves o t e runners 
Table 7 
l l f h d . th unng e stu ty pen d ·oo . 
April May August November 
T= 1.433 T= 2.226 T= 3.335 T- 2.910 
p = 0.166 p = 0.038* p = 0.003* p=0.009 * 
T= 1.469 T = 2.649 T= 3.228 T= 3.705 
D = 0.157 D = 0.015* P = 0.004* P = 0.002 * 
T= 1.174 T= 1.673 T= 2.873 T= 2.804 
D = 0.255 D = 0.112 D = 0.010* D= 0.012 * 
T = l.794 T = l.4Y2 T = 1.913 
D = 0.090 D = 0.154 D =0.073 
T= 2.129 T= 1.057 
.. D = 0.049* D = 0.306 
T=0.634 
D =0.534 
The month of December (used as a baseline) is compared with each of the other months 
studied. The individual months are also compared with each other. The T statistic and p 
value for each comparison is shown. (* = significant) 
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LH 
There were no significant changes in LH levels during the period under study (Table 8). 
In table 8 the T statistic and p values are included for the comparison of mean LH 
levels between the months indicated. LH minimum and maximum and mean levels for 
each study month remained within the normal range for males (Figures 8 and 9). 
Figure 8 
Maximum and minimum LH levels during the study period 
mlU/ml 






. n n ; I n l 1j 
. I n, I! 
4 ! I I / I ,I I j JI j 
1 
1 • I 1 1 1 / I i j 
1 1 ~ u1L,1 1 L 
I ;_: /
1 
f / L u u 
0 -' ____________________________ .......J 
DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV 
MONTH 
This illustates the maximum and minimum LH levels in mIU/ml of the runners for each 
of the months studied. The median value is indicated with the mark -. The normal range 
for LH in males is 1.5 - 9.2 mIU/ml. LH levels are shown on the y axis and the months are 


















Mean LH levels during the study period 
mlU/ml 
1.5'--I -- ---------' 
D J F M A M J J A S O N 
MONTH 
This illustrates the mean LH levels of the study group for each of the study months (mean 
+I= SEM). LH levels in mIU/ml are shown on the y axis and months are illustrated on 
the x axis. 
C ompansono f h LHI t e 
January February 
December T= 0.735 T= 0.237 
(baseline) p = 0.470 p = 0.815 
January T=0.576 







f th e runners d urm~ 
April May 
T = 1.461 T= 0.479 
p = 0.159 p = 0.637 
T= 1.166 T= 0.173 
p = 0.257 D = 0.865 
T = 0.911 T= 0.524 
p = 0.374 p = 0.606 
T = 1.404 
p=0.177 
th t d es u ty pen . 
AU2USt November 
T= 1.634 T = 1.168 
p = 0.119 p = 0.257 
T=0.840 T = 0.150 
p = 0.411 D = 0.882 
T= 1.387 T= 0.990 
p = 0.182 p = 0.335 
T = 0.353 T= OC'5 .5 
p = 0.729 D = 0.957 
T= 0.986 T= 0.223 
D = 0.339 p = 0.826 
T= 0.737 
D = 0.470 
The month of December (used as a baseline) is compared with each of the other months 
studied. The individual months are also compared with each other. The T statistic and p 







There were no significant changes in FSH levels during the period under study (Table 
9). In table 9 the T statistic and p values are included for the comparison of mean FSH 
levels between the months indicated. FSH minimum and maximum and mean levels for 
each study month remained well within the normal range for males (Figures IO and 
11). 
Figure 10 
Maximum and minimum FSH levels during the study period 
mlU/ml 
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DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV 
MONTH 
This illustates the maximum FSH levels (in mIU/ml) of the runners for each of the 
months studied. The median value is indicated with the mark -. The normal range for 
FSH in males is 1- 14 mIU/ml. FSH levels are shown on they axis and the months are 
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MONTH 
This illustrates the mean FSH levels of the study group for each of the study months 
(mean + / SEM). FSH levels in mIU/ml are shown on the y axis and months are 
illustrated on the x axis. 
C ompanson o 
January 
December T= 1.589 







f th FSH I l f h e eves o t e runners d . urmgt 
February April May 
T = 1.157 T= 0.445 T= 0.150 
p = 0.260 p = 0.661 p = 0.882 
T= 0.940 T = 1.061 T = 1.136 
p = 0.358 p = 0.301 o = 0.269 
T = 0.155 T= 0.496 
p = 0.878 p = 0.626 
T=n2t4 
p = 0.833 
h t d 'od es u 1y pen . 
Aui!USt November 
T = 0.511 T=0.834 
p = 0.615 p = 0.415 
T = 1.265 T= 1.845 
o = 0.221 p =0.081 
T= 0.479 T= 1.744 
p = 0.638 p=0.098 
T = 0.663 T = 0.791 
p = 0.517 p = 0.440 
T= 0.266 T=0.076 
o = 0.794 p = 0.940 
T=0.401 
p =0.693 
The month of December (used as a baseline) is compared with each of the other months 
studied. The individual months are also compared with each other. The T statistic and p 









There were no significant changes in testosterone concentrations during the period 
under study (Table 10). In table 10 the T statistic and p values are included for the 
comparison of mean testosterone levels between the months indicated. Testosterone 
minimum levels for each study month excluding December was found to be below the 
normal range. The mean testosterone level however remained within the normal range 
throughout the study. The maximum level was well within the normal range for males 
(Figures 12 and 13) 
Figure 12 
Maximum and minimum testosterone levels during the study period 
nmol/L 
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DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV 
MONTH 
This illustrates the maximum and minimum testosterone levels (in nmol/J) of the runners 
for each of the months studied. The median value is indicated with the mark-. The 
normal range for testosterone in males is 9.2 - 37 nmol/J. Testosterone levels are shown on 
they axis and the months are illustrated on the x axis. 
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Figure 13 







D J F M A M J J A S O N 
MONTH 
This illustrates the mean testosterone levels of the study group for each of the study 
months (mean + / - SEM). Testosterone levels in nmol/1 are shown on the y axis and 
months are illustrated on the x axis. 
Table 10 
C om oanson o f th I I f h e testosterone eve s o t e runners d . th tud unng es 1ypen . 
January Februarv April May AUi!USt November 
December T= 0.352 T= 0.186 T= 0.449 T= 0.372 T=0.143 T= 0.255 
(baseline) p =0.728 p = 0.854 p = 0.658 p = 0.714 p = 0.888 p = 0.802 
January T = 1.043 T = 1.023 T= 0.968 T= 0.939 T= 0.029 
D = 0.309 D = 0.318 D = 0.344 D = 0.360 D = 0.977 
February T= 0.222 T= 0.267 T= 0.007 T= 0.584 
D = 0.827 p = 0.793 D =0.994 D = 0.566 
April T = 0573 T = 0 JOI', T = 0.906 
p = 0.573 p = 0.847 p = 0.378 
May T= 0.270 T=0.044 




p = 0.340 
The month of December (used as a baseline) is compared with each of the other months 
studied. The individual months are also compared with each other. The T statistic and p 
value for each comparison is shown. No significant differences were noted. 
49 
The only significant change in E2 levels was an increase from January to May 
(T=2.081 p=0.050) (Table 11). However, when comparing the other months under 
study there were no significant changes. In table 11 the T statistic and p values are 
included for the comparison of mean E2 levels between the months indicated. 
Significant differences are shown with the asterix (*). E2 minimum and maximum 
levels for each study month remained within the normal range for males (Figure 14 and 
15). 
Figure 14 
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DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV 
MONTH 
This illustrates the maximum and minimum E2 levies (in pmol/1) of the runners for each 
of the months studied. The median value is indicated with the mark -. The normal range 
for E2 in males is 100 - 500 pmol/1. E2 levels are shown on they axis and the months are 




Mean E2 levels during the study period 
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This illustrates the mean E2 levels of the study group for each of the study months (mean 
+ I - SEM). E2 levels in pmol/1 are shown on the y axis and months are illustrated on the x 
axis. 
C ompansono fth 
January 
December T=0.448 
(baseline) p = 0.658 
January 
February 
Ap ri l 
May 
August 
emean eves o e runners 
Table 11 
E2 l l f th urm g es u ty pen d. th td . 
February April May Aui!USt November 
T= 0.837 T= 0.044 T= 1.942 T = 1.331 T = 1.045 
p = 0.412 p = 0.965 p = 0.066 p = 0.199 p = 0.309 
T = 1.211 T= 1.049 T= 2.081 T = 1.737 T = 1.437 
o = 0.239 o = 0.306 o = o.o5o* o=0.099 o =0.167 
T=0.302 T= 1.548 T = 0.381 T= 0.362 
p == 0.766 p==0.139 p = 0.707 p == 0.722 
T== l.3 71 T l.6 15 T == l.393 
o = 0.187 o = 0.125 p = 0.182 
T= 1.097 T = 0.147 
o =0.289 o = 0.885 
T= 0.058 
o = 0.954 
The month of December (used as a baseline) is compared with each of the other months 
studied. The individual months are also compared with each other. The T statistic and p 




The semen volume decreased significantly decrease between months December and 
April (T=2.144 p=0.044), December and November (T=2.394 p=0.027) and August and 
November. (T=2.952 p=0.009). A significant increase was noted between April and 
August (T=2.307 p=0.033) and May and August (T=2.548 p=0.021). All other months 
studied did not show any significant differences (Table 12). In table 12 the T statistic 
and p values are included for the comparison of mean semen volume between the 
months indicated. Significant differences are shown with the asterix (*). The minimum 
and maximum and mean values are represented in Figures 16 and 17. 
Figure 16 
Maximum and minimum semen volume during the study period 
ml. 
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MONTH 
This illustrates the maximum and minimum semen volume (in ml) of the runners for 
each of the months studied. The median value is indicated with the mark -. The normal 
range for semen volume is 2.0 - 6.0 ml. Semen volume is shown on the y axis and months 
are illustrated on the x axis. 
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Figure 17 
Mean semen volume during the study period 
ml. 
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This illustrates the mean semen volumes of the study group for each of the study months 
(mean + / - SEM). Semen volume in ml is shown on the y axis and months are illustrated 
on the x axis. 
Table 12 
C ompansono f h t l f h e mean semen vo umes o t e runners d . unn~ t h d 'od e stu y pen . 
January February April May August November 
December T= 1.371 T=0.753 T=2.144 T = 1.120 T= 0.812 T= 2.394 
(baseline) p = 0.184 p = 0.460 p = 0.044 * p = 0.277 D = 0.427 p = 0.027 * 
January T= 0.512 T= 0.530 T= 0.775 T=0.917 T= 1.361 
D = 0.614 D = 0.601 D = 0.447 D = 0.370 D = 0.189 
February T = 1.018 T = 1.837 T= 0.721 T = 1.696 
p = 0.321 p = 0.083 D = 0.480 p = 0.108 
A;: ril ! = U.U-1-l T = 2.307 T = 0.019 
p = 0.965 o = 0.033* o = 0.544 
May T= 2.548 T= 0.346 
o = 0.021 * o =0.734 
August T= 2.952 
p = 0.009 * 
The month of December (used as a baseline) is compared with each of the other months 
studied. The individual months are also compared with each other. The T statistic and p 





There were no significant changes in the semen count during the period under study 
(Table 13). In table 13 the T statistic and p values are included for the comparison of 
mean semen counts between the months indicated. The minimum and maximum and 
mean values are represented in Figures 18 and 19. 
Figure 18 
Maximum and minimum semen count during the study period 
1x10~ml 
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MONTH 
This illustrates the maximum and minimum semen count (in 1 x 106 / ml) of the runners 
for each of the months studied. The median value is indicated with the mark -. The 
normal range is for semen count is > 20 x 106 / ml. Semen count is shown on the y axis 
and the months are illusated on the x axis. 
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Figure 19 
Mean semen count during the study period 
1x1d7ml 
180 '' ,,,,,,, ,,,,,,,,,,.,, 
160 :: : .... · 
60 : 
40~· ~·· -----""--~~~~~~~~~~~~~~ 
D J F M A M J J A S O N 
MONTH 
This illustrates the mean semen count of the study group for each of the study months 
(mean + / - SEM). Semen count in 1 x 106 is shown on the y axis and months are 
illustrated on the x axis. 
C ompanson o f h t 
January 








f h e mean semen count o t 
February April 
T = 1.199 T=0.649 
p =0.245 p = 0.523 
T= 0.871 T= 0.556 
P = 0.384 P =0.584 
T= 0.521 
P = 0.609 
-
-
e runners d . unngt h d .d e stu ly peno . 
May August November 
T= 1.007 T= 0.795 T = 1.572 
p = 0.327 p = 0.437 p=0.132 
T = 0.231 T= 0.603 T= 0.904 
P = 0.820 p = 0.553 p = 0.378 
T= 0.100 T= 0.042 T = 1.229 
P = 0.922 P = 0.967 P = 0.236 
T=0.6n T = I ?..,n T = o.son 
p = 0.510 p = 0.238 p = 0.623 
T = 1.249 T= 0.040 
p =0.229 p =0.968 
T= 1.499 
P=0.151 
The month of December (used as a baseline) is compared with each of the other months 
studied. The individual months are also compared with each other. The T statistic and p 









Semen motility decreased significantly from December to April (T=2.434 p=0.024) 
and also when comparing May to August (T=2.828 p=0.012). However all other 
months studied did not show any significant changes (Table 14). In table 14 the T 
statistic and p values are included for the comparison of mean semen motility between 
the months indicated. The significant differences are shown with the asterix (*). The 
minimum and maximum and mean values are represented in Figures 20 and 21. 
Figure 20 
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This illustrates the maximum and minimum semen motility (expressed as a percentage of 
motile spermatozoa) of the runners for each of the months studied. The median value is 
indicated with the mark -. The normal range for semen motility is > 40% motile 
spermatozoa. Percentage of motile semen is shown on the y axis and the months are 
illustrated on the x axis. 
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Figure 21 




.. ..... . .. .... .. . . 
45 ~· ~~~~~~~~~~~~~~~~------' 
D J F M A M J J A S O N 
MONTH 
This illustrates the mean semen motility of the study group for each of the study months 
(mean + / - SEM). The percentage of motile sperm is shown on the y axis and months are 
illustrated on the x axis. 
Table 14 
Comparison of the mean semen motility of the runners during the study period. 
January February April May August November 
December T= 0.743 T= 1.504 T= 2.434 T=l.116 T = 1.969 T = 1.285 
(baseline) p = 0.466 p = 0.148 p = 0.024* p = 0.278 p = 0.064 p = 0.214 
January T = 1.268 T = 1.733 T=0.165 T = 1.702 T= 0.825 
p = 0.219 P = 0.098 P = 0.871 P = 0.105 p = 0.419 
February T= 0.603 T= 0.889 T= 0.288 T= 0.187 
D = 0.554 D = 0.385 D = 0.776 o= 0.854 
April T = 1.511 T= 0.329 T= 0.498 
p = n 148 n - 0.746 p = n 625 
May T= 2.828 T= 1.295 
D = 0.012* D = 0.214 
August T= 0.800 
-
p = 0.435 
The month of December (used as a baseline) is compared with each of the other months 
studied. The individual months are also compared with each other. The T statistic and p 
value for each comparison is shown. (* = significant) 
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Semen Morphology 
There was a significant decrease in semen morphology between December (baseline) 
and January (T=2.796 p=0.011), February (T=2.955 p=0.008), April (T=2.626 
p=0.016), May (T=3.202 p=0.005), August (T=2.534 p=0.021) and November 
(T=3.727 p=0.001). However no other significant differences were demonstrated after 
the initial fall (Table 15). In table 15 the T statistic and p values are included for the 
comparison of mean semen morphology between the months indicated. Significant 
differences are shown with the asterix (*). The minimum and maximum and mean 
values are represented in Figures 22 and 23. 
Figure 22 
Semen morphology during the study period. 
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This illustrates the maximum and_minimum semen morphology (expressed as a 
percentage of morphologically normal spermatozoa) of the runners for each of the 
months studied. The median value is indicated with the mark-. The normal range for 
semen morphology is> 40% of morphologically normal spermatozoa. The percentage of 
morphologically normal semen is shown on the y axis and the months are illustrated on 
the x axis. 
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Figure 23 
Mean percentage of the morphologically normal spermatozoa during the study period 
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This illustrates the mean of the morphologically normal spermatozoa of the study group 
for each of the study months (mean + / - SEM). Percentage of morphologically normal 
spermatozoa is shown on the y axis and the months are illustrated on the x axis. 
Table 15 
Comparison of the mean of the morphologically normal spermatozoa of the runners 
d . d 'od unng the stu ly J>en . 
January February April May Au=t November 
December T= 2.796 T= 2.955 T= 2.626 T= 3.202 T= 2.534 T= 3.727 
{baseline) p=0.011* p =0.008* p = 0.016* p = 0.005* D = 0.021* D = 0.001* 
January T= 0.309 T= 0.630 T = 0.119 T= 0.799 T= 0.156 
o = 0.760 D = 0.536 o = 0.907 0 = 0.435 o =0.878 
February T = 0.911 T= 0.424 T = 0.557 T= 0.342 
P = 0.374 o = 0.677 o = 0.534 D = 0.736 -
April T =- 0. 780 T = 0 , ,; _-; T=0.22 1 
o = 0.445 o = 0.221 O= 0.828 
May T= 0.428 T=0.105 
- o =0.674 o=0.917 
August T= 0.090 
o =0.930 
The month of December (used as a baseline) is compared with each of the other months 
studied. The individual months are also compared with each other. The T statistic and p 
value for each comparison is shown. (* = significant) . 
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Low and High Training. 
Results were analysed by dividing the runners each month into two groups according to 
the distance trained each week. Each individual runner could only be represented in one 
group and this group could change from month to month according to the distance run 
in the preceding week. Low training involved running up to 55 kilometres per week and 
high training included training between 60 and 160 kilometres per week. The mean 
training distance in the low group was 28.7 (SD 18.5) kilometres and in the high group 
84.9 (SD 20.8) kilometres. 
Seventy-three results were analysed in the low group and 78 results in the high training 
group. Runners results who had no training for a particular month were excluded from 
the analysis. Only one runner had a training distance of 160 kilometres and only on one 
occasion. When comparing the results between low training time and high training time 
(Table 16) there was a significant fall in FSH levels, with a mean value of 4.0 mIU/ml 
for low training and a mean value of 3.5 mIU/ml for high training (T=2.203 p=0.029). 
There was however no significant differences in the mean values between high and low 
training for any of the other hormones measured. Mean LH values for high training 
were 2.6 mIU/ml and for low training 2.9 mIU/ml (T=l.089 p=0.278). Mean E2 values 
for high training were 243 pmol/1 and for low training 254 pmol/1 (T=l.200 p=0.232). 
This also was the case for testosterone, with the mean value for high training being 14.7 
nmol/1 and for low training 14.5 nmol/1 (T=0.282 p=0.779), prolactin, with the mean 
value for high training being 3.7 ng/ml and low training 4.2 ng/ml (T=l.827 p=0.070) 
and progesterone, with the mean value for high training being 0.8 nmol/1 and for low 
training 0.7 nmol/1 ff= 1.374 p=0.172). 
The mean semen volume for high training was 2. 7 ml and for low training was 2.8 ml. 
(T=0.626 p=0.532). The mean semen motility for high training was 54% and for low 
training was 55% (T=0.512 p=0.610). There was however a significant difference in 
semen count and semen morphology when comparing months of high training with 
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months of low training. The mean semen count for high training months was 133 
million/ml and for low training 71 million/ml (T=3.459 p=0.001). The mean semen 
morphology during high training was 15% and for low training 11 % (T=3.416 
p=0.001). 
There was a significant difference in weight between months of high training and 
months of low training. The mean weight for high training was 72.0 kg and for low 
training 76.6 kg (T=2.923 p=0.004). However BMI did not change significantly. The 
mean value for high training was 23.2 kg/m2 and for low training 24.1 kg/m2 (T=l.969 
p=0.051). 
Table 16 
Comparison of the mean hormonal, semen and anthropomorphic parameters of the 
f d . .od f h' h d I group o runners urmg pen so II an ow tramm •. 
High training Low training T value p value 
mean (SD) mean (SD) 
number= 78 number= 73 
Hormones 
FSH (mIU/ml) 3.5 (1.5) 3.0 (1.5) 2.203 0.029* 
LH(mIU/ml) 2.6 (1.4) 2.9 (1.4) 1.089 0.278 
E2 (pmol/1) 243 (66.2) 254 (54.5) 1.200 0.232 
Testosterone (nmol/1) 14.7 (4.3) 14.5 (4.4) 0.282 0.779 
Prolactin (ng/ml) 3.7 (1.6) 4.2 (2.0) 1.827 0.070 
Pro2esterone (nmol/1) 0.8 (0.4) 0.7 (0.3) 1.374 0.172 
Semen 
Volume (m~ 2.7 (1.4) 2.8 (1.4) 0.626 0.532 
Count (xlO /ml) 133 (142) 71 (65) 3.459 0.001 * 
Motility(%) 54 (9) 55 (8) 0.512 0.610 
Momb0Io2v (%) 15 (6) 11 (7) 3.416 0.001 * 
Weight (kg) 72.0 (10.0) 76.6 (9.0) 2.923 0.004"' 
BMI(kwm2) 23.2 (2.8) 24.1 (2.3) 1.969 0.051 
The T statistic and p value for each comparison is shown (* = significant) 
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DISCUSSION 
The purpose of this study was to determine if there were changes in hormone levels and 
semen parameters in a group of athletes training for marathon running. Although the 
occurrence of hypogonadotropic hypogonadism in female athletes is a well described 
entity (Jacobs, 1982; Reame et al., 1985), very limited attention has been paid to the 
possibility of a similar phenomenon occurring in male athletes. The effects of strenuous 
physical exercise on the reproductive system in men have been evaluated in 
uncontrolled situations in the majority of reports often with only single-point 
measurements of reproductive hormones. In addition, the degree of previous training, as 
well as the intensity of the short-term exercise, was not standardised (MacConnie et al., 
1986). 
In this longitudinal study serial serum hormonal and semen analysis was performed 
over a year long period in a group of marathon runners. The increase in training . 
distance was in preparation for the Two Oceans marathon, a 56 km race, which was run 
in April. Thereafter there was a gradual decrease in training times (Figure 1). The 
marathon took place in the fifth month of the study. The runners' weight decreased as 
training time increased in preparation for the marathon. This was obviously paralleled 
by a decrease in the body mass index, which remained however, within the normal 
range. Whilst it has been shown that females who have weight loss during training have 
more significant menstrual cycle alterations (Bullen et al, 1985), the correlation of 
weight changes with semen parameters and reproductive dysfunction in males has not 
been well defined. 
In this study the effect of long distance running on the hypothalamic-pituitary-gonadal 
axis was studied. Other investigators have studied the effect of exercise on the pituitary-
adrenocortical system, but this only involved the determination of a single blood 
cortisol level in response to exercise (Jurimae et al., 1989). The increased blood cortisol 
level observed by Jurimae reflects an increase in adrenocortical activity, but as only a 
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single measurement was done in response to strenuous exercise the long-term effect of 
this remains to be defined. Highly trained male athletes have been reported to have 
deficient GnRH secretion (MacConnie et al., 1986), and also the term "over-training" 
has been related to the hypothalamic dysfunction provoked by exercise (Barron et al., 
1985). Exercise induced infertility seems to be less common in men than in women 
(Ayers et al., 1985), with findings suggesting that the threshold for exercise or training 
induced H-P-G axis suppression is much higher in men than in women. 
A number of biological rhythms are known to exist in man (Smolensky, 1980). There is 
the one-hourly rhythm of pituitary response to GnRH secretion, or the circadian (24 
hour) rhythm of the excretion of steroid hormones such as oestrogen, progesterone and 
testosterone (Politoff et al., 1989). All specimens were taken between 7.00 am and 9.00 
am to minimise possible variations introduced by diurnal rhythms. 
Evaluation of the hormonal profile in our group of 24 marathon runners showed that 
although there was a significant initial increase in the prolactin levels and fall in 
progesterone, both of these remained within the normal range for males. Prolactin 
levels showed an increase when comparing baseline samples taken in December prior to 
the start of strenuous training to those of the other months studied. The effect of 
strenuous training on prolactin levels in males remains to be well defined. In contrast to 
our study, Aakvaag reported a suppression of prolactin during a five day combat course 
involving army personnel (Aakvaag et al., 1978). These findings were confirmed in a 
study by Wheeler who demonstrated a reduction in prolactin levels in a group of male 
distance runners, although the levels remained (as in our study) within the normal range 
(Wheeler et al .. 1984). The study by Wheeler involved the determination of a single 
prolactin level in contrast to our study which was a longitudinal study performed over a 
period of a year. However, in a recent study Hackney et al suggested that enduranced-
trained subjects had normal resting prolactin, but following the injection of a dopamine 
antagonist had higher prolactin levels than a sedentary group (Hackney et al., 1990). 
The significance of the initial increase in prolactin levels in our group of runners is 
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uncertain and requires further investigation. The physiological significance of prolactin 
in the male is currently uncertain. However, an increase in prolactin may be significant 
as prolactin may influence testicular function (Aakvaag et al. , 1978). There are 
prolactin receptors in the adult human testis and it has been suggested that prolactin 
may also be involved in regulating testicular sex steroid production (Rubin et al., 
1978). Prolactin is necessary for normal manufacture of sex steroids within the testis 
but when present in an increased quantity may result in decreased testosterone 
production and impaired libido (Wheeler et al., 1984). However it is difficult to 
attribute the decreased libido anecdotally reported in some runners during intense 
training to changes in testosterone only, as chronic fatigue may also be important. 
However, the effect of prolactin on the H-P-G axis is also central and this may be 
important in endurance-trained athletes as training could, via endogenous opioids result 
in an increased response of the lactotropic cells of the pituitary. Other possibilities 
include a decreased short-loop prolactin-dopamine feed-back or suppressed prolactin -
prolactin inhibition (Hackney et al, 1990). Alterations in circulating prolactin alone 
cannot explain the serum testosterone changes seen in runners (Cumming et al., 1989). 
As prolactin levels in this study were within the normal range for adult males it would 
seem unlikely the alterations in the semen parameters of the runners were due to these 
changes. 
The median testosterone levels in this group of runners were at the lower end of the 
normal range, a finding consistent with those of McColl and co-workers (McColl et al., 
1989). However, several studies have shown a decrease in serum testosterone levels in 
male athletes (Ayers et al, 1985; Hackney et al, 1990). The fall in serum testosterone 
levels may result from decreased production rates , decreased binding or increased 
clearance. There is scant evidence of decreased binding (Wheeler et al., 1984). The 
clearance of testosterone is through both hepatic and extrahepatic mechanisms. There 
are no studies demonstrating long term increases in hepatic or extrahepatic clearance of 
testosterone in endurance-trained or other athletes. Wheeler et al, in a more recent 
article, stated that the lower testosterone levels in exercising men are probably the result 
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of peripheral mechanisms such as an increase in tissue testosterone utilisation without 
triggering any changes in gonadotropin release (Wheeler et al., 1991). Ayers confirmed 
the observation of decreased serum testosterone levels in the majority of male subjects 
undergoing endurance training, but despite these depressed gonadal steroid levels, this 
was not associated with a decrease in fertility potential (Ayers et al., 1985). Despite the 
alterations in gonadal steroids, 18 of the 20 subjects they studied had no evidence of a 
concomitant effect on sperm production. Furthermore, they found no correlation 
between testosterone and sperm counts and suggested either that male spermatogenesis 
and steroidogenesis have separate control mechanisms, or that this "down-setting" of 
testosterone steroid production has little effect on the testicular sperm production of 
endurance athletes (Ayers et al., 1985). What is clear from their study is that significant 
physical exercise and chronic endurance training alone are not associated with a 
detrimental effect on sperm production in most men. While testosterone was 
significantly decreased in their subjects, most did not demonstrate the profound 
disturbance in reproductive function seen in similarly trained female athletes. 
Wheeler provided evidence that vigorous physical exercise in men may have chronic 
effects on H-P-G axis function similar to those changes seen in female endurance 
athletes (Wheeler et al., 1984). The results of our study confirmed their observations of 
a decreased serum testosterone level with the mean value in the lower range of normal 
for males. However there was no further significant fall in testosterone levels as the 
training progressed. Therefore although spermatogenesis is an androgen dependent 
biological function, it is unlikely that the lower testosterone levels, which did not 
change specifically over the study period, found in our runners produced any significant 
clinical impact on the semen parameters. 
The lack of significant changes in LH and FSH levels observed in our study, a finding 
consistent with the results of Wheeler, implies that impaired gonadotropin release is not 
responsible for the lower testosterone levels (Wheeler et al. , 1984). This finding does 
not exclude more subtle alterations in GnRH-pituitary function . Luteinizing hormone is 
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generally accepted as the pituitary gonadotropin controlling testosterone secretion 
(Sutton et al., 1973). These findings support the lack of association between androgens 
and luteinizing hormone observed by other workers (Cartensen et al., 1972; Rogol et 
al., 1984). Exercise does not seem to affect mean serum LH levels (Wall et al., 1985). 
This finding by Wall and co-workers was confirmed in our study where no significant 
changes in LH values over the year long period. As the serum levels of LH and FSH 
remained within the normal range for males and did not change significantly over the 
study period, they do not appear to play a part in the altered semen parameters in our 
runners. 
The estradiol levels remained constant throughout the study period. Female athletes 
with hypothalamic amenorrhoea have low serum levels of estrogen (Reame et al., 
1985). In female runners with normal menstrual cycles, episodes of intense exercise 
have been associated with elevated plasma concentrations of estradiol (Jurkowski et al., 
1978). In a study by Ayers et al mean estradiol concentrations did not differ from 
control values. The mean estradiol concentration was, however, deceptive, because in 
75% of the runners the mean values were markedly lower than the control range (Ayers 
et al., 1985). In another study of male marathon runners each subject had normal serum 
concentrations of estradiol (Rogol et al. , 1984). In our study the estradiol values 
remained within the normal range for males throughout the year long follow-up. 
Estrogen formation in the testes is regulated by gonadotropins and as the LH and FSH 
remained unchanged during the study it seems logical that the estradiol levels should 
remain constant and therefore unlikely to cause the alterations in the semen parameters 
in the study group. 
There is very little information available on progesterone levels in male athletes. In 
men, progesterone is formed as an intermediate link in the biosynthesis of other steroid 
hormones. Although the function of progesterone in the male is not known the Leydig 
cells in the testes secrete small quantities and the adrenal gland is also capable of 
producing small amounts. A study by Jurimae showed a considerable increase in 
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progesterone levels after long triathlons. Comparison with this study is not valid 
however as Jurimae sampled the triathletes on one occasion only (immediately after the 
event) (Jurimae et al., 1989). In contrast this study has looked at serial samples over a 
year. Although the levels fell significantly they remained within the normal range for 
males. It could be postulated that if the progesterone levels decrease this could lead to 
the lower testosterone levels seen in runners and indicate a decrease in production and 
not a change in clearance as proposed by Wheeler (Wheeler et al., 1984). More 
evidence is needed. However, as the progesterone levels remained within the normal 
range for males throughout the study, it seems unlikely that the alterations in the semen 
parameters in our runners has any relationship to progesterone levels. 
The effect of major athletic competition on hormonal levels, libido and sperm 
production remains largely unexplored. The general perception has been that strenuous 
exercise is not associated with a significant decrease in fertility, but this is probably a 
reflection of a lack of available data rather than scientific facts. Baker has suggested 
that a decrease in fertility may occur in males who participate in strenuous physical 
activity (Baker et al., 1984.). In addition anecdotal data have also suggested that libido 
may be impaired in some runners during periods of intense endurance training (Wheeler 
et al., 1984). The aetiology of this is not clear. Reduced testosterone levels may play a 
role but chronic fatigue could also be a significant factor (Wheeler et al., 1984). As 
libido is a very subjective condition and, in addition to this, is may be influenced by 
factors other than exercise, it was not analysed as a variable in this study. 
The period of continence preceding collection of the semen specimen has a remarkable 
influence n spermatozoan crmceni•·ation but has little effect on motility or morphology 
(Freund, 1963). In this study no fixed period of continence was specified. A fixed· 
period of continence preceding the collection of a specimen means that the specimen is 
no longer a random sampling of the patient's spermatozoan _ output at his usual 
frequency of ejaculation. It has been shown that individuals respond quite differently to 
experimental variations in the frequency of intercourse and duration of continence; 
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some men show very large changes in spermatozoan output, and some quite modest 
changes (Freund, 1963). 
The age of the specimen at the time of examination, that is the time elapsed from 
collection at home to examination in the laboratory, is of great importance, since it has 
been demonstrated that at room temperature (20-250C) the percent motility and forward 
progression of spermatozoa declines by half in the first seven hours after collection 
(Freund, 1963). In this study the semen sample was either collected in the laboratory or 
immediately prior to attending the regular follow-up visit. All were examined within six 
hours of collection. This optimisation of semen san1ple collection enabled us to 
minimise the chance of erroneous results due to a delay in specimen processing. 
A specimen bottle was supplied to each runner to be used at the next semen collection. 
By supplying the bottle it was possible to avoid the problem of receiving specimens in a 
variety of used and possibly contaminated containers like drug, food or cosmetic 
bottles. The plastic containers used in this study were those routinely used to obtain 
donor semen samples at the infertility clinic at Groote Schuur Hospital. It had been 
previously demonstrated that these containers had no effect on spermatozoan motility 
and survival and therefore suitable for the analysis of semen samples. 
Precise semen analysis, mainly comprising count, motility and morphology analysis, 
remain the most important investigation for determining fertility potential in the male. 
It is well known that semen values must be carefully interpreted since wide fluctuations 
0f semen paran1eters as well as limitatio1:s and inaccc:·:ic ies of l!1e var: ,1us me hods and 
the investigators bias the results. In this study all semen san1ples were analysed by the 
same experienced laboratory technologist to limit these factors. 
In this study the semen volume was noted to decrease when comparing December to 
April and November. However there was a significant increase in semen volume 
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between April and August. This change was inversely proportional to the training time. 
The mean volume was never below 2 ml in any specific month of study and this is 
reassuring as authorities in the field of semen parameters agree that a fall in volume 
below 1 ml in total may influence conception rates (Macleod, 1973; Baker, 1984). 
Baker defined a low semen volume as <2.0 ml and this correlated positively with poor 
pregnancy rates in their artificial insemination by donor program when compared with a 
group with semen volume >2.0 ml (Baker, 1984). It is clear that although the semen 
volume changed during the study period these changes would probably not compromise 
fertility potential. 
No difference in the mean semen count was demonstrated over this year long study and 
this finding was consistent with the findings of Bagatell who studied a group of male 
marathon runners for 12 weeks. They suggested that long term, strenuous exercise does 
not exert major effects on reproductive function in men. They found no difference in 
mean sperm counts between exercising and sedentary men (Bagatell and Bremner, 
1990). Although the sperm count per millilitre is not of paramount importance, it is the 
parameter according to which patients' semen is classified, and remains the parameter 
which can be explained easily to patients to offer them a relative understanding of 
fertility prognosis (Van Zyl, 1980). Macleod considers that true oligospermia is 
represented in counts under 20 million/ml and at that level, provided the sperm motility 
is good, the chance of conception is reasonably good, and also states that conceptions 
occurring at higher sperm count levels are not in proportion to the rise in sperm count 
(Macleod, 1973) In another study Ayers et al found that despite alterations in gonadal 
steroids, 18 of the 20 men had no evidence of a concomitant effect upon sperm 
production . Tr c.' rc was also no correlation between testosterone levels and sperm count, 
these authors suggested either that male gametogenesis and steroidogenesis have 
separate control mechanisms, or that the "down-setting" of testicular steroid production 
has little effect on testicular sperm production of endurance athletes (Ayers et al. , 
1985). In a more recent study however, Griffith et al noted a decrease in semen count 
(although not significant) in a group of athletes undergoing exhaustive endurance 
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training for two weeks (Griffith et al., 1990). The findings in our study that the highest 
mean semen count was found during December do not correlate with the findings of 
Levine et al who noted a reduction in semen counts in summer when compared with 
winter (Levine et al., 1990). However, the lowest mean semen count in this study was 
found in November. Whether this change is due to exercise or seasonal variations is not 
clear and needs further investigation. 
In contrast to the study by Bagatell who found no consistent abnormality of motility in 
their runners' semen samples (Bagatell and Bremner, 1990) in our study a significant 
decrease in sperm motility was noted between December and April, and May and 
August. Acre et al confirmed a significantly reduced sperm motility in a group of 
endurance trained runners when compared to sedentary controls (Acre et al., 1993). As 
the sperm motility decreased significantly between December and May, the increase in 
training time might have had some influence on these changes, other factors being 
equal. Motility is of paramount importance, since patients with an adequate sperm 
count per ml but impaired motility and those with a relatively poor count per ml but 
exceptionally good sperm motility deserve careful evaluation to determine fertility 
prognosis (Van Zyl, 1980). 
The evaluation of sperm morphology is a controversial issue. Normal morphology 
evaluated by strict criteria is a valuable predictor of fertility (Kruger et al., 1988). 
Semen morphology decreased significantly from baseline when compared with all other 
months studied. The mean normal sperm morphology was consistently less than 14% 
which is in contrast to the study by Bagatell who found no abnormalities of morphology 
in their runners semen sam ples (Bagate ll and Bremner, 1990). This is a significant 
finding as there is excellent correlation with the percentage normal sperm morphologic 
features and fertilisation and pregnancy rates. In a study by Kruger the group of patients 
with <14% normal morphologic features had significantly lower fertilisation and 
pregnancy rates (Kruger et al. , 1986). These findings are not insignificant as the 
decrease in sperm morphology may compromise future fertility. However, whether 
70 
these alterations are a result of the endurance training needs further investigation as the 
sperm morphology should have returned to December mean levels as the training 
decreased. This did not occur however, but the time taken for normal spermatogenesis 
of seventy days might be a significant factor. 
When comparing the results between months of low training and high training the only 
significant difference in the hormonal parameters was found with FSH levels. The 
mean FSH in months of high training was 3.49 nmol/1 and in months of low training 
was 4.03 nmol/1 (T = 2.203: p = 0.029). Although not strictly comparable, this does 
contrast to the findings of Bagatell who found no difference in mean FSH levels 
between a matched group of marathon runners and healthy, lean controls (Bagatell et 
al., 1990). Circulating FSH levels are regulated by non-steroidal factors from the 
seminiferous tubules with inhibin being the most clearly identified substance from this 
source which reduces serum FSH levels at the pituitary. It is not known whether inhibin 
also exerts a negative feed-back control at a hypothalamic locus, but testosterone, and 
estradiol are also capable of inhibiting secretion of FSH (Sherins et al., 1982). 
However, there was no significant difference in testosterone or estradiol levels in the 
two groups so some other mechanism must influence the suppression of FSH mean 
levels in the high training group. Clearly more detailed endocrinological studies are 
necessary as the effect of exercise on hormonal changes is immediate while the semen 
changes might be delayed for several months. In addition in this study a confounding 
problem was the ability of a runner to move from the low training group to high 
training group within a two month period. It is not therefore possible to compare 
hormonal changes and alterations in semen parameters within a single month. 
The effect of major athletic competition on sperm production remains largely 
unexplored and the hormonal" regulation of spermatogenesis in man is poorly 
understood. FSH is believed to be required for spermatid maturation (spermiogenesis) 
and during the initiation of spermatogenesis at the time of puberty. However the role of 
FSH in the maintenance of sperm production in adults is unclear. Matsumoto et al have 
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shown that stimulation of sperm production can occur despite undetectable serum FSH 
levels and concluded therefore that normal levels of FSH are not an absolute 
requirement for re-initiating spermatogenesis (Matsumoto et al, 1986). In this study 
when the months of high training were compared with the months of low training 
significant differences in semen counts and semen morphology were noted. The mean 
semen count was higher in the group in the high training months and the mean normal 
morphology was also higher in this group when compared with the group in low 
training months. However, there were no differences in semen volume and semen 
motility between the two groups. It must be remembered that the process of 
spermatogenesis takes a period of approximately seventy days to be completed. 
Therefore by analysing semen in a specific month hormonal influences that have taken 
place over the preceding two months must be taken into consideration. The rate of 
spermatogenesis cannot be altered by hormonal suppression or stimulation, other toxic 
agents such as radiation or a change in temperature. 
Spermatogenesis is under control of FSH and LH, whose secretion is regulated by 
gonadal steroids and inhibin (Knuth et al., 1989). Although the mean serum FSH levels 
in both high and low training groups were within the normal range for males, the mean 
was significantly lower in the high training group. When looking at the changes in 
spermatogenesis seen in low months, it must be remembered that these might actually 
be the influence of high training in the previous two or three months. High training 
months preceded by low training will probably have no effect on sperm with the 
seventy day cycle of maturation. In the study by Matsumoto et al on patients with 
prolonged severely suppressed FSH levels, all eight subjects had significant but not 
complete suppression of spermatogenesis although this was highly variable between the 
subjects (Matsumoto et al, 1986). Testosterone is essential for primary spermatocytes 
to complete meiosis and there is general agreement that testosterone is the physiological 
feed-back inhibitor of LH in man (Sutton et al., 1973). The differences in semen 
parameters in the high and low training groups are probably multifactoral with 
hormonal influences, stress and possibly temperature variations playing the most 
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critical roles. The findings of this study are confusing as it does not make sense that 
heavy training should give better semen parameters than months of low training. 
However, the "better" semen parameters seen in the high training group may have been 
the result of fewer ejaculations during the high training months due to a decrease in 
libido that has been anecdotally reported in some runners during intense training. It is 
known that the frequency of ejaculation can influence semen parameters. 
When comparing the mean weight in the high and low training groups there was a 
significant lower weight in the months of high training. This can be expected as the 
runners would probably at their leanest and in peak physical condition in preparation 
for the marathon during the period of high training. Weight loss interacts in an additive 
way with exercise to alter fertility potential. However, the months of peak physical 
condition will only have a possible effect on semen parameters in two to three months 
due to the constant rate of spermatogenesis. The lower body weight would not be 
expected to influence the runners fertility immediately. 
Although the effect of strenuous exercise on fertility in men remains to be well defined, 
a study involving an artificial insemination programme showed that partners of donors 
who participated in strenuous exercise with low semen volumes had significantly lower 
pregnancy rates than partners of men with normal activity and a low semen volume. 
When semen volume was normal there was no reduction in fertility (Wall et al., 1985). 
Despite significant physical exercise ( 40 - 80 miles/week) and chronic endurance 
training in Ayers' study there was no associated detrimental effect on sperm production 
in most men (Ayers et al., 1985). 
A cause-effect relationship between fertility and endurance training is difficult to 
demonstrate because of the presence of life-style variables which may also influence the 
reproductive system. The hormonal milieu necessary for the initiation and maintenance 
of spermatogenesis in man is poorly understood. It remains to be clarified whether 
exercise related elevation of prolactin (which remain, however, within normal limits), 
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as demonstrated in this study, will be accompanied by a decrease in fertility . It may be 
argued that these alterations are subclinical in nature and do not warrant fertility 
concerns. 
Further investigations are necessary to determine if testicular function is temporarily or 
permanently compromised by long periods of endurance training, similar to menstrual 
changes in female athletes, and what effect this has on fertility . Reduction in physical 
exercise in female athletes or an optimal diet is often enough to restore normal 
menstrual cycles. It needs to be determined by further studies if similar measures would 
improve semen parameters. 
This study has demonstrated, as in a recent study (Acre et al. , 1993), that endurance 
training can modify hormonal profiles and semen parameters quantitatively and 
qualitatively in long distance runners. However, the pathophysiological mechanisms 
explaining the alterations in spermatogenesis are unclear but it is almost certainly 
multifactoral in nature and could include increased scrotal temperature, inadequate 
dietary intake for energy expenditure and nutritional deficiencies and not only due to 
endurance training. At present it is unclear whether the hormonal changes and alteration 
in semen parameters as defined in this study will cause a reduction in fertility potential 
and further studies in the future should address this issue. 
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CONCLUSION 
This study demonstrated changes in both the hormonal profile and semen parameters in 
a cohort of male marathon runners. An important difference between this study and 
many of the previous studies performed was that this was a prospective, longitudinal 
study of a relatively large group of runners over a period of a year. In addition the 
runners were monitored regularly whilst they were preparing for a marathon. 
Prolactin levels were noted to increase, a finding consistent with the study of Shangold, 
who noted increased prolactin concentrations in women runners after acute strenuous 
exertion (Shangold et al., 1981). Although the progesterone levels fell significantly 
during the study, they remained with the normal range for males, as did all other 
hormonal and gonadotropin assays. 
Precise semen analysis, mainly comprising volume, count, motility and morphology, 
remains the most important investigation of fertility potential in male marathon runners. 
In this study the mean semen volume decreased from December to April, but then 
increased again between April and August. The semen count remained unchanged 
throughout the study, but both the mean semen motility and mean normal morphology 
decreased between the beginning of the study and April, the month of maximum 
training. 
At present it is unclear whether the laboratory changes observed in this study will result 
in the clinical expression of reduced fertility and further studies are required in this 
fascinating fi eld of reproductive medicine. 
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APPENDIX 1 
Key to raw data tables 
NI A Not available 
Neg Negative 
Pos Positive 
Weight in kilogrames 
BMI in kilogrames/meter squared 
FSH in ng/ml 
LH in ng/ml 
E2 in nmol/1 
Testosterone in ng/ml 
Prolactin in ng/ml 
Progesterone in nmol/1 
Semen volume in mls. 
Semen count in million/ml. 
Motility in percentage 
Morphology in percentage 




Table Number Runner's Initials Page 
17. J.A. 78 
18. B.C. 78 
19. H.H. 79 
20. B.J. 79 
21. A.B. 80 
22. R.K. 80 
23. M.K. 81 
24. R.L. 81 
25. I.M. 82 
26. C.M. 82 
27. A.P. 83 
28. M.P. 83 
29. G.R. 84 
30. F.S. 84 
31. R.S. 85 
32. H.S. 85 
33. G.S. 86 
34. D.T. 86 
35. P. v.d.L. 87 
36. B.v.Z. 87 
37. J.v.Z. 88 
38. G.W. 88 
39. G.Wa. 89 
40. D.W. 89 
88 
Table 17: Runner JA 
,ge: years; e1g t A 41 H. h 183 cm 
December January February April May AUPUSt 
November 
Weight 83.5 82.5 83.5 82.0 84.5 
84.5 84.5 
BMI 24.9 24.6 24.9 24.9 24.5 
25.2 25.2 
Hormone 
FSH 3.3 3.9 3.9 3.6 3.5 
3.7 3.6 
LH 1.3 3.7 3.0 2.6 1.9 1.
5 1.1 
E2 235 279 327 275 313 
282 244 
Testosterone 13.3 16.6 15.1 13.8 13.l 17
.6 13.0 
Prolactin 3.9 3.1 2.0 1.8 2.9 4.0 
3.1 
Pro1?.esterone 0.7 0.4 0.5 0.4 0.5 0.3 
0.4 
Semen 
Volume 2.0 2.5 2.9 2.4 2.5 2.7 
l.2 
Count 30.0 31.0 44.0 32.0 34.0 37.0 
35.0 
Motility 65 60 40 60 60 55 55 
Morphology 5 9 4 4 4 6 7 
MAR Nel?. Nel?. Nel?. Ne!! Ne!! Ne!! N
e!! 
Distance run 0 40 50 60 15 80 35 
oer week 
Table 18: Runner BC 
A 46 H . ht 178c ,ge: years; e1g m 
December January February April May AU!!USt November 
Weight 72.0 71.5 69.8 71.0 71.0 NIA NIA 
BMI 22.7 22.6 22.0 22.4 22.4 NIA NIA 
Hormone 
FSH 3.1 3.1 2.9 2.9 3.0 NIA NIA 
LH 1.2 1.8 1.2 1.0 1.8 NIA NIA 
E2 279 334 256 429 375 NIA NIA 
Testosterone 13.2 13.6 14.0 13.4 14.8 NIA NIA 
Prolactin 2.2 2.0 2.5 3.1 3.3 NIA NIA 
Pro1?.esterone 0.9 0.8 0.7 0.4 0.5 NIA NIA 
Semen 
Volume 2.0 1.2 1.0 1.8 0.5 NIA NIA 
Count 425 260 490 750 740 NIA NIA 
Motility 60 55 40 40 50 NIA NIA 
Morphology 15 12 20 19 17 NIA NIA 
MAR Nel?. Nel?. Ne!! Ne!! Neg NIA NIA 
Distance run 60 75 70 70 60 NIA NIA 
per week 
89 
Table 19: Runner HH 
,ge: years; etg t A SO H. h 173 cm 
December January Februarv April Mav August 
November 
Weight 74.5 76.5 73.5 74.5 74.0 75.0 
75.5 
BMI 24.9 25.6 24.6 24.9 24.7 25.0 
25.3 
Hormone 
FSH 4.1 3.8 3.9 3.7 4.2 3.7 
3.4 
LH 3.2 2.6 2.3 2.5 2.6 2.6 
3.1 
E2 230 183 211 174 186 196 
234 
Testosterone 10.4 14.l 13.8 13.8 14.3 13.3 
14.7 
Prolactin 2.9 3.1 2.4 3.3 3.0 3.0 
3.0 
Pro_gesterone 0.6 0.5 0.5 0.7 0.5 0.5 1.0
 
Semen 
Volume 3.3 4.0 5.7 4.8 3.5 4.0 
4.0 
Count 210 202 200 175 206 159 
111 
Motility 65 55 45 40 60 65 55 
Morphology 21 20 20 14 16 13 16 
MAR Ne2 Ne!! Ne!! Ne!! Ne2 Ne!! 
Ne_g 
Distance run 60 60 80 100 110 55 55 
per week 
Table 20: Runner BJ 
A 31 H . h 185 ,ge: years; e1g: t cm 
December Januarv Februarv April Mav AU!YUSt November 
Weight 87.2 85.5 82.5 82.5 84.0 89.5 90.5 
BMI 25.5 25.l 24.l 24.l 24.6 26.2 26.5 
Hormone 
FSH 3.6 4.2 3.9 4.3 3.8 4.0 3.1 
LH 3.2 4.2 3.0 3.5 3.8 3.0 1.4 
E2 284 245 279 272 247 243 242 
Testosterone 16.0 15.0 19.4 22.9 23.4 20.3 13.2 
Prolactin 3.4 2.6 5.2 4.8 6.6 6.1 5.4 
Pro_gesterone 1.2 0.9 0.7 1.0 0.7 0.6 0.4 
Semen 
Volume 1.5 1.5 1.0 1.5 0.5 1.0 2.4 
Count 93 45 19 70 4 18 103 
Motility 55 40 35 45 40 35 60 
Morphology 22 9 7 12 8 13 11 
MAR Neg Neg Neg Neg Neg Ne!! Neg 
Distance run 40 45 80 60 50 10 30 
per week 
90 
Table 21: Runner AB 
,ge: years; Hei2ht 7 A 46 1 9 cm 
December January February Avril Mav Aul!Ust November 
Weight 82.0 78.0 80.0 81.0 NIA 83.0 86.5 
BMI 25.6 24.4 25.0 25.3 NIA 25.0 27 
Hormone 
FSH 5.0 5.5 5.9 5.5 NIA 5.7 5.1 
LH 6.3 5.2 6.7 6.1 NIA 6.3 6.6 
E2 325 334 315 394 NIA 339 363 
Testosterone 20.l 25.3 22.5 24.3 NIA 22.l 18.6 
Prolactin 2.9 5.8 5.3 8.5 NIA 12.0 10.0 
Progesterone 0.8 0.9 0.7 0.6 NIA 1.0 0.5 
Semen 
Volume 1.8 0.8 2.0 0.7 NIA 1.5 1.3 
Count 20 l 52 35 NIA 46 47 
Motility 45 65 55 50 NIA 50 45 
Morphology l l 2 l NIA l l 
MAR Neg Neg Neg Neg NIA Neg Neg 
Distance run 40 30 40 20 NIA 10 0 
oer week 
Table 22: Runner RK 
A 29 H. h 175 ,ge: years; e1gJ t cm 
December January Februarv Avril Mav AU!711St November 
Weight 73.5 73.5 72.0 73 .5 73.5 NIA NIA 
BMI 24.0 24.0 23.5 24.0 24.0 NIA NIA 
Hormone 
FSH 2.5 2.2 2.2 2.4 2.3 NIA NIA 
LH 3.8 3.0 1.4 1.6 1.9 NIA NIA 
E2 237 198 219 238 275 NIA NIA 
Testosterone 17.8 17.2 18.2 18.5 17.3 NIA NIA 
Prolactin 2.6 5.5 3.4 3.8 4.6 NIA NIA 
Progesterone 0.5 1.1 0.5 0.9 1.0 NIA NIA 
Semen 
Volume 2.3 1.4 1.8 1.8 3.8 NIA NIA 
Count 60 87 4:l 47 25 NIA NIA 
Motility 65 55 60 60 45 NIA NIA 
Morphology 26 22 20 28 25 NIA NIA 
MAR Neg Neg Ne!! Neg Neg NIA NIA 
Distance run 30 80 90 100 80 NIA NIA 
oer week 
91 
Table 23: Runner MK 
,ge: years; eie t A 32 H. h 178c m 
December January February Aoril May AUP'l.lSt November 
Weight 70.0 69.0 68.8 NIA 70.0 70.0 70.0 
BMI 22.1 21.8 21.7 NIA 22.1 22.1 22.1 
Hormone 
FSH 2.5 3.1 3.2 NIA 3.1 3.2 2.5 
LH 3.7 3.7 3.1 NIA 2.7 3.7 2.8 
E2 284 340 328 NIA 352 311 493 
Testosterone 13.9 16.8 18.5 NIA 20.6 19.1 23.1 
Prolactin 2.2 2.8 2.6 NIA 2.4 3.3 2.9 
Proeesterone 0.9 1.0 0.7 NIA 0.8 0.7 0.8 
Semen 
Volume 1.6 2.2 2.5 NIA 1.8 2.0 2.0 
Count 135 151 142 NIA 121 45 145 
Motility 60 55 60 NIA 65 60 65 
Morphology 22 8 12 NIA 13 8 17 
MAR Neg Neg Nee NIA Nee Neg Nee 
Distance run 50 100 160 NIA 0 100 llO 
oer week 
Table 24: Runner RL 
A 36 H. h 174 .ge: years; e1g t cm 
December January February Aoril May AuITTist November 
Weight 67.9 65.1 68.5 68.0 66.5 69.2 68.0 
BMI 22.4 21.5 22.6 22.4 21.9 22.8 22.4 
Hormone 
FSH 6.0 6.8 6.6 6.4 5.0 6.0 5.8 
LH 5.0 5.8 7.8 4.1 4.5 5.6 5.3 
E2 227 170 173 191 221 247 261 
Testosterone 16.0 19.5 16.5 15.8 16.7 15.4 19.7 
Prolactin 2.8 5.1 5.3 6.7 4.6 5.1 6.3 
Proeesterone 0.5 0.5 0.5 0.3 0.2 0.3 0.4 
Semen 
Volume 1.4 2.3 2.0 1.8 2.0 1.8 0.8 
Count 34 34 39 38 30 36 26 
Motility 60 65 60 55 60 65 45 
Morphology 20 19 14 13 15 16 21 
MAR Ne!! Ne!! Nee. Ne!! Neg Neg Ne!! 
Distance run 30 100 11 5 125 'iO 7'i 75 
oer week 
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Table 25: Runner IM 
A 39 ,ge: years; Height 171cm 
December January February April Mav Aueust November 
Weight 58.0 57.0 58.5 58.0 59.6 60.5 61.0 
BMI 19.9 19.5 20.0 19.9 20.4 20.7 20.9 
Hormone 
FSH 1.6 1.5 1.7 1.4 1.8 1.5 1.7 
LH 1.7 1.0 0.8 1.1 1.7 0.9 1.3 
E2 163 169 135 172 187 184 168 
Testosterone 13.6 6.4 6.8 10.3 13.7 11.0 15.7 
Prolactin 3.4 2.9 2.6 3.1 4.7 7.6 4.4 
Pro!!esterone 0.6 0.6 0.5 0.5 0.6 0.9 0.4 
Semen 
Volume 3.2 2.0 3.8 3.2 2.8 3.3 2.4 
Count 56 108 110 136 91 66 73 
Motility 55 55 60 55 55 55 65 
Morphology 22 21 22 21 19 19 17 
MAR Ne!! Ne!! Ne!! Ne!! Ne!! Ne!! Ne!! 
Distance run 110 100 100 110 125 100 85 
per week 
Table 26: Runner CM 
A 28 H ' ht 163 ,ge: years; e1g cm 
December January February April Mav Aueust November 
Weight 54.5 54.5 54.5 NIA 54.5 56.5 54.5 
BMI 20.5 20.5 20.5 NIA 20.5 21.2 20.5 
Hormone 
FSH 1.8 2.2 2.2 NIA 2.2 2.7 2.6 
LH 2.2 1.7 4.1 NIA 1.9 2.1 3.8 
E2 243 307 275 NIA 311 266 206 
Testosterone 22.8 20.5 17.0 NIA 21.6 21.4 22.0 
Prolactin 1.2 1.1 1.5 NIA 2.2 1.7 2.3 
Pro_gesterone 1.0 1.1 1.0 NIA 1.2 0.8 1.0 
Semen 
Volume NIA 4.5 5.0 NIA 3.0 3.3 NIA 
Count NIA 150 243 NIA 150 205 NIA 
Motility NIA 50 35 NIA 50 40 NIA 
Morphology NIA 15 11 NIA 10 22 NIA 
MAR NIA Neg Neg NIA Neg Neg NIA 
Distance run 90 100 90 NIA 120 110 80 
per week 
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Table 27: Runner AP 
A 25 H . ht 177 ge: years; e1g. cm 
December January February April May Aui,ist November 
Weight 79.5 83.5 83.5 85.5 83.0 89.0 89.0 
BMI 25.4 26.7 26.7 27.3 26.5 28.4 28.4 
Hormone 
FSH 2.7 2.6 2.5 2.8 2.6 2.2 2.4 
LH 3.3 3.4 1.7 2.4 2.0 3.5 4.3 
E2 370 279 296 302 333 315 301 
Testosterone 13.1 8.9 7.9 9.2 8.0 10.6 10.4 
Prolactin 1.9 1.9 3.1 4.1 3.7 4.4 4.3 
Progesterone 0.8 0.7 0.4 0.2 0.4 0.2 0.4 
Semen 
Volume 2.3 2.2 1.9 1.5 1.5 3.0 1.0 
Count 220 154 97 124 166 156 63 
Motility 60 65 55 60 65 55 55 
Morphology 7 12 14 10 9 12 10 
MAR Neg Neg Neg Neg Neg Neg Neg 
Distance run 40 60 50 70 90 20 0 
per week 
Table 28: Runner MP 
A 53 H . ht 180 5 .ge: years; e1g . cm 
December January February April May Aug-ust November 
Weight 72.5 71.0 71.8 71.0 70.5 73.5 72.0 
BMI 22.4 21.9 21.2 21.9 21.8 22.7 22.2 
Hormone 
FSH 6.0 5.3 5.5 5.7 6.1 5.6 6.2 
LH 1.8 1.9 1.4 2.2 1.6 1.4 1.3 
E2 229 247 199 197 175 208 237 
Testosterone 17.0 8.9 5.9 6.4 7.2 6.6 6.3 
Prolactin 1.2 4.0 2.2 2.0 3.9 2.5 2.5 
Progesterone 0.7 0.7 0.9 1.0 0.6 0.3 0.5 
Semen 
Volume 3.0 2.8 2.8 2.6 2.8 2.5 1.2 
Count 430 172 138 146 146 168 44 
Motility 50 50 60 40 45 50 50 
Morpholvgy 20 16 19 22 26 24 12 
MAR Neg Neg Ne_g Neg Neg Neg Neg 
Distance run 80 65 110 110 35 0 55 
per week 
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Table 29: Runner GR 
,ge: 1 vears; Height A 3 179 cm 
December January February Avril Mav Au£USt November 
Weight 75.4 73.5 74.0 73.6 75.0 75.0 NIA 
BMI 23.7 23.0 23.1 23.0 23.4 23.4 NIA 
Hormone 
FSH 4.8 8.2 5.3 5.9 5.8 6.5 NIA 
LH 4.5 4.2 4.4 3.4 5.5 5.3 NIA 
E2 239 122 296 211 316 276 NIA 
Testosterone 20.6 19.4 19.4 19.2 17.4 15.9 NIA 
Prolactin 5.2 3.8 5.1 7.1 7.7 7.2 NIA 
Progesterone 1.7 0.9 1.5 1.2 1.1 0.8 NIA 
Semen 
Volume 3.8 2.6 3.3 3.4 3.2 3.0 NIA 
Count 45 11 33 39 10 7 NIA 
Motility 50 50 45 50 50 50 NIA 
Morphology 15 NIA 4 7 2 3 NIA 
MAR Neg Neg Neg Neg Neg Neg NIA 
Distance run 60 80 100 110 110 40 NIA 
oer week 
Table 30: Runner FS 
A 35 H. 63 .ge: years; eight 1 cm 
December January February April Mav Aul!llst November 
Weight 53.5 55.0 55.5 54.0 56.0 57.5 57.0 
BMI 20.1 20.7 20.9 2013 21.1 21.6 21.4 
Hormone 
FSH 3.5 3.2 2.6 2.8 3.2 2.8 3.1 
LH 2.0 1.6 1.3 1.4 1.7 1.5 1.7 
E2 237 223 259 226 223 211 221 
Testosterone 11.3 13.8 16.6 9.3 16.1 14.2 17.5 
Prolactin 2.6 4.7 6.4 4.8 7.1 6.5 4.8 
Progesterone 0.5 0.8 0.4 0.4 0.5 0.4 0.4 
Semen 
Volume 2.8 3.2 1.7 2.5 2.0 3.3 2.8 
Count 132 74 40 57 65 185 130 
Motility 65 50 65 60 65 50 50 
Morphology 23 4 14 10 15 15 15 
MAR Neg Neg Pos Pos Pos Pos Pos 
Distance run 80 100 80 30 0 30 50 
per week 
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Table 31: Runner RS 
,ge: years; e1g A 37 H . ht 178c m 
December January February April Mav Au1!0St November 
Weight 72.0 70.5 NIA 70.5 73.5 NIA 71.5 
BMI 22.7 22.2 NIA 22.2 23.2 NIA 22.6 
Hormone 
FSH 2.0 2.2 NIA 1.9 2.1 NIA 1.9 
LH 2.3 2.3 NIA 1.5 2.0 NIA 2.4 
E2 227 193 NIA 211 257 NIA 268 
Testosterone 9.8 11.7 NIA 11.6 9.6 NIA 12.9 
Prolactin 2.4 3.0 NIA 5.0 5.0 NIA 4.9 
Pro1?esterone 0.9 1.2 NIA 1.1 0.9 NIA 1.2 
Semen 
Volume 1.2 0.8 NIA 0.4 0.8 NIA 0.4 
Count 73 107 NIA 25 25 NIA 26 
Motility 65 65 NIA 50 65 NIA 50 
Morphology 22 23 NIA 14 23 NIA 18 
MAR Neg Ne!? NIA Ne!? Neg NIA NIA 
Distance run 80 100 NIA 100 40 NIA 0 
per week 
Table 32: Runner HS 
A 38 H . ht 178c .ge: years; e1g1 m 
December January February April May Aul!llst November 
Weight 65.7 66.0 65.0 65.0 63.0 64.8 67.0 
BMI 20.7 20.8 20.5 20.5 19.9 20.4 21.l 
Hormone 
FSH 3.4 2.7 3.3 3.4 3.4 3.1 3.3 
LH 2.9 2.7 3.5 2.8 3.4 1.5 1.3 
E2 239 234 263 244 237 283 211 
Testosterone 10.7 10.7 17.5 17.8 5.5 9.2 5.8 
Prolactin 2.1 5.0 4.3 4.0 3.7 2.9 2.7 
Progesterone 1.4 0.7 1.3 1.1 0.9 0.9 0.4 
Semen 
Volume 4.6 4.0 4.5 2.4 4.8 4.8 5.3 
Count 140 188 56 17 18 1 28 
Motility 45 45 55 40 50 NIA 45 
Morphology 16 11 7 12 4 NIA 6 
MAR Neg Neg Neg Ne!! Ner Ner Neg 
Distance run 0 0 45 50 60 0 0 
per week 
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Table 33: Runner GS 
.ge: years; eight A 32 H . 180 cm 
December Januarv February Aoril Mav Aul!llst November 
Weight 69.0 69.0 67.5 66.5 67.0 69.0 68.5 
BMI 21.3 21.3 20.8 20.5 20.7 21.3 21.1 
Hormone 
FSH 3.3 3.6 3.4 3.2 3.5 3.4 3.1 
LH 3.0 2.4 2.8 4.1 2.9 3.1 3.3 
E2 192 199 192 240 207 223 249 
Testosterone 18.9 15.1 14.2 14.2 14.2 12.5 13.9 
Prolactin 2.7 5.1 3.9 4.8 4.2 3.1 5.6 
Progesterone 1.3 1.8 1.6 1.6 1.3 1.0 1.1 
Semen 
Volume 3.3 2.3 2.2 2.8 1.5 3.0 3.5 
Count 290 152 330 170 230 260 164 
Motility 60 55 55 70 60 60 55 
Morphology 16 10 13 16 15 21 20 
MAR Neg Ne11, Neg Nee Nee Ne!! Nee 
Distance run 60 75 70 65 50 40 40 
per week 
Table 34: Runner DT 
A 30 6c .ge: years; Height 17 m 
December January February April Mav AUl!USt November 
Weight 76.5 77.0 75 .0 76.0 NIA 78.0 77.5 
BMI 24.8 24.9 24.3 24.6 NIA 25.2 25 .1 
Hormone 
FSH 3.9 4.0 3.7 3.5 NIA 4.6 3.7 
LH 3.8 2.7 2.4 1.3 NIA 2.4 1.9 
E2 248 212 266 230 NIA 334 246 
Testosterone 16.2 15 .0 16.2 13.7 NIA 18.0 11.8 
Prolactin 2.8 7.9 9.3 7.8 NIA 5.0 3.9 
Progesterone 1.4 1.6 1.1 1.5 NIA 1.2 1.0 
Semen 
Volume 4.3 2.2 2.0 3.0 NIA 5.0 2.0 
Count 137 118 126 155 NIA 185 103 
Motility 60 55 40 55 NIA 65 60 
Morphology 23 13 18 13 NIA 25 16 
MAR Ne!! Neg Neg Ne!! NIA Ne!! Nee 
Distance run 30 40 70 10 NIA 40 30 
per week 
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Table 35: Runner PvdL 
.ge: years; eag, A 40 H. ht 174 cm 
December January February April May Au2:ust November 
Weight 92.5 93.3 92.0 92.5 91.7 93.5 94.5 
BMI 30.5 30.8 30.4 30.5 30.3 30.9 31.2 
Hormone 
FSH 3.1 2.9 3.6 4.1 2.8 3.1 3.1 
LH 2.0 2.4 2.8 4.3 3.4 2.7 2.4 
E2 100 133 153 144 212 206 188 
Testosterone 10.9 11.5 11.5 10.2 12.5 13.8 9.6 
Prolactin 2.4 3.4 3.6 2.9 1.7 2.0 2.8 
Pro2esterone 0.5 0.7 1.0 0.7 0.7 0.9 0.4 
Semen 
Volume 1.2 1.0 1.8 0.5 1.5 2.8 1.5 
Count 96 44 119 103 100 270 172 
Motility 60 60 50 40 60 40 40 
Morphology 20 17 16 21 15 8 14 
MAR Neg Neg Neg Neg Neg Neg Neg 
Distance run 40 70 80 80 100 70 25 
per week 
Table 36: Runner BvZ 
A 47 H . ht 190 ,ge: years; eag cm 
December Januarv February April May August November 
Weight 83.0 84.5 84.0 82.0 81.7 82.2 85 .0 
BMI 23 .0 23.4 23.3 22.7 22.6 22.8 23.5 
Hormone 
FSH 3.2 2.9 3.0 3.0 3.3 2.9 2.9 
LH 2.8 0.8 0.9 1.6 1.4 1.0 3.3 
E2 293 279 327 275 313 282 244 
Testosterone 12.5 10.4 11.2 12.0 12.3 13.4 12.8 
Prolactin 1.9 4.8 5.2 4.3 4 .7 5.0 4 .5 
Progesterone 0.4 0.6 0.7 0.4 0.5 0.5 0.7 
Semen 
Volume 2.0 1.8 2.5 2.2 2.8 2.8 1.5 
Count 32 52 72 86 38 26 62 
Motility 50 65 65 45 60 55 60 
Morphology 11 9 7 10 3 2 3 
MAR Neg NC!! NC!! Neg Neg Neg Neg 
Distance run 40 60 50 65 65 40 40 
per week 
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Table 37: Runner JvZ 
ge: years; e1g A 46 H . ht 174 cm 
December January February April May AUl!USt November 
Weight 69.5 68.0 69.5 69.5 NIA 72.0 72.5 
BMI 22.9 22.4 22.9 22.9 NIA 23.8 23.9 
Hormone 
FSH 5.9 6.2 6.5 6.8 NIA 6.5 5.5 
LH 2.4 2.7 3.0 3.3 NIA 2.7 1.8 
E2 280 230 312 133 NIA 295 261 
Testosterone 19.6 16.9 21.2 16.2 NIA 17.7 13.1 
Prolactin 1.9 4.8 5.6 4.5 NIA 3.1 4.4 
Proe:esterone 0.6 1.2 0.7 0.2 NIA 0.4 0.3 
Semen 
Volume 5.3 3.8 2.8 3.0 NIA 5.0 3.0 
Count 3 14 11 14 NIA 12 5 
Motility 60 50 65 60 NIA 60 65 
Morphology 4 3 5 2 NIA 5 2 
MAR Nee: Nee: Nee: Nee: NIA Neg Ne~ 
Distance run 0 30 50 55 NIA 10 50 
oer week 
Table 38: Runner GW 
A 25 H . ht 186c ,ge: years; e1g m 
December January February April May AuITTJSt November 
Weight 82.4 79.2 78.6 83.3 82.5 83.5 85.0 
BMI 23.8 22.9 22.7 24.1 23.8 24.1 24.6 
Hormone 
FSH 2.1 2.6 2.2 2.3 2.4 2.3 2.2 
LH 2.0 2.6 2.2 1.6 3.7 2.3 2.8 
E2 173 286 211 222 254 216 221 
Testosterone 10.3 14.1 19.1 20.1 18.7 18.8 14.7 
Prolactin 3.2 3.4 3.3 5.4 4.3 2.8 2.7 
Pro~esterone 0.8 0.5 0.7 0.7 0.6 0.3 0.3 
Semen 
Volume 6.8 9.0 6.3 5.2 4.5 5.0 4.8 
Count 49 73 37 31 39 18 15 
Motility 60 65 60 65 60 45 65 
Morphology 9 14 10 14 8 6 9 
MAR Neg Neg Neg Neg Neg Ne!! Neg 
Distance run 20 70 60 50 20 20 10 
oer week 
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Table 39: Runner GWa 
.ge: years; e1g . A 46 H . ht 174 5 cm 
December January February April May August November 
Weight 79.0 80.5 78.0 81.0 80.0 81.0 84.0 
BMI 26.1 26.6 25.7 26.7 26.4 26.7 27.7 
Hormone 
FSH 7.4 7.6 7.0 5.6 5.6 5.1 7.5 
LH 4.8 1.7 5.7 1.6 1.6 l.l 2.4 
E2 246 197 218 245 172 183 249 
Testosterone 10.3 9.5 IO.I 13.4 9.6 9.4 12.7 
Prolactin 2.6 2.4 3.6 3.8 2.2 3.5 4.0 
Pro_gesterone 0.7 0.5 0.5 0.3 0.3 0.3 0.3 
Semen 
Volume 4.0 4.0 4.2 5.2 4.3 5.0 4.3 
Count 11 10 15 15 23 l l 7.6 
Motility 60 60 60 50 45 40 40 
Morphology 6 7 3 6 7 9 4 
MAR Pos Pos Pos Pos Pos Pos Pos 
Distance run 0 15 60 80 30 15 0 
per week 
Table 40: Runner DW 
A 54 H ' ht 178 ge: years; e1g1 cm 
December January February April May August November 
Weight 89.0 89.0 NIA NIA NIA NIA NIA 
BMI 28.2 28.2 NIA NIA NIA NIA NIA 
Hormone 
FSH 2.4 2.6 NIA 2.6 3.1 NIA NIA 
LH 1.0 2.1 NIA 1.6 3.0 NIA NIA 
E2 266 333 NIA 282 302 NIA NIA 
Testosterone 13.7 15.2 NIA 18.9 17.2 NIA NIA 
Prolactin 1.9 2.5 NIA 3.5 4.0 NIA NIA 
Pro_gesterone 0.3 0.4 NIA 0.6 0.3 NIA NIA 
Semen 
Volume 2.5 2.5 NIA 2.5 3.0 2.0 2.0 
Count 57 64 NIA 52 34 188 155 
Motility 45 50 NIA 60 55 50 60 
Morphology 19 6 NIA 9 15 l l 17 
MAR Neg Neg NIA Neg Neg Neg Neg 
Distance run 60 60 NIA NIA NIA NIA NIA 
per week 
